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Abstract
Mathematical modelling of the HIV/AIDS epidemic and the ef-
fect of public health education
Maku Vyambwera
MSc Dissertation, Department of Mathematics and Applied Mathematics, University of
the Western Cape.
HIV/AIDS is nowadays considered as the greatest public health disaster of modern time.
Its progression has challenged the global population for decades. Through mathematical
modelling, researchers have studied different interventions on the HIV pandemic, such as
treatment, education, condom use, etc. Our research focuses on different compartmen-
tal models with emphasis on the effect of public health education. From the point of
view of statistics, it is well known how the public health educational programs contribute
towards the reduction of the spread of HIV/AIDS epidemic. Many models have been
studied towards understanding the dynamics of the HIV/AIDS epidemic. The impact
of ARV treatment have been observed and analysed by many researchers. Our research
studies and investigates a compartmental model of HIV with treatment and education
campaign. We study the existence of equilibrium points and their stability. Original con-
tributions of this dissertation are the modifications on the model of Cai et al. [1], which
enables us to use optimal control theory to identify optimal roll-out of strategies to con-
trol the HIV/AIDS. Furthermore, we introduce randomness into the model and we study
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the almost sure exponential stability of the disease free equilibrium. The randomness
is regarded as environmental perturbations in the system. Another contribution is the
global stability analysis on the model of Nyabadza et al. in [3]. The stability thresholds
are compared for the HIV/AIDS in the absence of any intervention to assess the possible
community benefit of public health educational campaigns. We illustrate the results by
way simulation
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[1 ] L. Cai, Xuezhi Li, Mini Ghosh, Boazhu Guo. Stability analysis of an HIV/AIDS
epidemic model with treatment, 229 (2009) 313-323.
[2 ] C.P. Bhunu, S. Mushayabasa, H. Kojouharov, J.M. Tchuenche. Mathematical
Analysis of an HIV/AIDS Model: Impact of Educational Programs and Abstinence
in Sub-Saharan Africa. J Math Model Algor 10 (2011),31-55.
[3 ] F. Nyabadza, C. Chiyaka, Z. Mukandavire, S.D. Hove-Musekwa. Analysis of an
HIV/AIDS model with public-health information campaigns and individual with-
drawal. Journal of Biological Systems, 18, 2 (2010) 357-375.
Through this dissertation the author has contributed to two manuscripts [4] and [5], which
are currently under review towards publication in journals,
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and sensitivity of an HIV model with public health education (under submission).
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Chapter 1
General Introduction
1.1 Intoduction to HIV/AIDS
Acquired immune deficiency syndrome or acquired immunodeficiency syndrome (AIDS) is
a disease of the human immune system caused by human immunodeficiency virus (HIV).
For more information refer to Sepkowitz [46]. AIDS has developed into a global pan-
demic (which is an epidemic of infectious disease that spreads through human population
across a large region, continent or worldwide) since the first patients were identified in
1982. However, the early history of HIV in South Africa was contained, like in the early
phase of the epidemic elsewhere, among gay men. In 1982, two homosexual men were
diagnosed with HIV. Out of 250 blood specimen taken from homosexual men in Johan-
nesburg, South Africa’s largest city, 32 were infected. Half the sample had more than
20 different sexual partners in 12 months. The initial concentration of HIV within the
gay community led to the belief that AIDS was a homosexual disease, with the wider
population largely ignoring the risk, and the apartheid government excusing itself from
acting. It is currently reported that 34 million people currently living with with HIV, 2.5
million are being newly infected and 1.7 million AIDS death occurred in 2011, [57]. It
was reported that South Africa’s national AIDS plan was to focus on the rapid scale-up
of HIV treatment and almost 2 million people are now on ARV as compared to fewer than
1
 
 
 
 
1 million in 2009, [57].
1.1.1 HIV Transmission
Many people still misunderstand the process of transmission of HIV from one person to
another, see [56] of Kim for instance. Knowing the basics helps you avoid getting the
virus if you are HIV-negative, and avoid giving it to someone else if you are HIV-positive.
HIV is transmitted through direct contact of a mucous membrane or the bloodstream
with a bodily fluid containing HIV such as blood, semen, vaginal fluid and breast milk.
The disease can be passed during unprotected sex with an HIV-infected person. HIV is
not spread through body fluids such as sweat, tears or saliva (spit). The spread of HIV
can be prevented. There are ways to avoid, or at least reduce, contact with body fluids
that spread HIV.
1.1.2 Methods of Transmission
In the past, HIV was spread accidentally by transfusion with blood products, such as
whole blood or the factor used by hemophiliacs. Many people were infected this way.
The blood supply is now much more strictly tested and controlled. The odds of being
infected from receiving blood or blood factor in SA are very low. One cannot get HIV
from donating blood if a new sterile (clean) needle is used for each donation, see [56].
An HIV-infected mother can transmit HIV to her infant during pregnancy, delivery or
while breastfeeding. Medical care and HIV drugs given during pregnancy can almost
eliminate the risk of a baby getting HIV from its mother. HIV-positive mothers should
not breastfeed their babies. People can also become infected with HIV when using in-
jection drugs through sharing needles and other equipment. This risk may be reduced
by cleaning needles with a bleach solution before re-using them. However, some experts
question how effective this method really is in reducing transmission. It is best to use
2
 
 
 
 
fresh needles each time to eliminate any risk of infection. Many cities offer free needle
exchange programs. Tattoos or body piercings should always be done by a licensed pro-
fessional whose equipment is autoclaved, not just sterilized with alcohol.
Every sexual act (oral, anal, or vaginal) that involves sexual fluids of some kind has at
least some risk. Barriers, such as condoms (male and female), dental dams (thin squares of
latex), and latex gloves help reduce risk substantially. Unsafe sex (sex without condoms or
barriers) puts you and your partner at risk for HIV or other sexually transmitted diseases
(STDs). Safer sex (sex using condoms or other barriers correctly and consistently) protects
you and your partner.
1.1.3 How HIV is not Transmitted
HIV cannot be transmitted except when certain body fluids are exchanged. One can
greatly reduce the risk of transmission by:
• Avoiding contact with sexual fluids by always practicing safer sex.
• Abstaining from sex unless you and your partner are both HIV-negative and in a
long-term, monogamous relationship.
• Not injecting drugs, or if you do, always using new or clean needles.
• Finding out your HIV status if you are planning to get pregnant and working with
a knowledgeable health care provider and obstetrician if you are HIV-positive.
If you protect yourself in these ways, you do not need to be afraid of getting or passing
HIV by casual contact. HIV is not transmitted by hugs, dancing, sharing food or drinks,
using a shower, bath, or bed used by an HIV-positive person, kissing (between people
with no significant dental problems), sharing exercise equipment, bug bites, see [56].
3
 
 
 
 
Over time, infection with HIV can weaken the immune system to the point that the
system has difficulty fighting off certain infections. These types of infections are known
as opportunistic infections. These infections are usually controlled by a healthy immune
system, but they can cause problems or even be life-threatening in someone with AIDS.
The immune system of a person with AIDS has weakened to the point that medical
intervention may be necessary to prevent or treat serious illness.
1.2 Immunology of HIV/AIDS
The Human immunodeficiency virus, HIV, infects cells in the immune system and the
central nervous system. The T-helper lymphocytes are the main types of cell that HIV
infects. The role of these cells in the immune system is to coordinate the actions of other
immune system cells. A large reduction in the number of these cells results in weakening
the immune system. HIV infects the T-helper cells because it has the protein called CD4+
on its surface, which HIV uses to attach itself to the cells before entering to them. For
more information see the book of Ronald [45] and Brauer [9]. That is why the T-helper cell
is referred to as CD4+T lymphocyte. Once it attaches itself into a cell, HIV produces new
copies which are capable of infecting other cells. When the age of infection increases, HIV
infection leads to a severe reduction in the number of T-helper cells which are responsible
to help fight diseases.
1.2.1 Stages of HIV/AIDS
The evolution of the virus in the human body, and the response of the body typically
takes several years. According to WHO (World Health Organization) clinical staging of
HIV/AIDS, HIV infection has four distinct stages: primary infection stage, asymptomatic
stage, symptomatic stage, and advanced AIDS stage, we refer the reader to [44]. Know-
ing what stage of HIV infection an individual is in can help physicians design treatment
plans. In order to diagnose an individual as being in a specific stage of HIV, the World
Health Organization (WHO) developed a set of criteria that can be used worldwide. The
4
 
 
 
 
criteria rely on symptoms, instead of CD4 and viral load test, since many developing coun-
tries do not have the facilities to perform these complicated tests. This staging system
helps clinicians to decide whether the patient is eligible for treatment or not, especially in
resource-constrained setting where CD4+ count measurement or other diagnostic methods
are not yet developed.
Stage 1: Primary HIV infection
The first stage of HIV infection is called primary infection. Primary infection begins
shortly after an individual first becomes infected with HIV. This stage lasts for a few
weeks. During this period, individuals experience symptoms similar to the flu. Very few
individuals seek treatment during this time, and those who do are usually misdiagnosed
with a viral infection. Often, if an HIV test is performed, it will come back negative, since
antibodies are not yet being produced by the individual’s immune system. Since antibod-
ies have not yet developed, HIV continues to replicate and results in very high levels of
the virus, see Ejigu [18]. In the first few weeks after being infected, infected individuals
are highly infectious. At this stage there is a large amount of HIV in the peripheral blood
(the blood in the circulating system not in the lymphatic system, bone marrow, liver or
speen), around 106 copies of virus per µl of blood. Antibodies and cytotoxic lymphocytes
start being produced as a response to the virus which is known as sero-conversion. At
this stage about 20 percent of people who are HIV positive show symptoms which are not
mild. However, the diagnosis of HIV infection is missed at this stage. Those who believe
they have been exposed to HIV should repeat the test after six months.
Stage 2: Asymptomatic HIV
In the second stage, individuals are free from any symptoms of HIV although there may
be swollen glands. Levels of HIV in the blood are very low, but are detectable. If an HIV
test is performed, it will come back positive. While the individual is asymptomatic, the
HIV in their blood is reproducing constantly. This stage lasts about ten years, but can
be much longer or shorter depending on the individual and is characterized by a CD4+
5
 
 
 
 
count around 500 cells per µl.
Stage 3: Symptomatic HIV
In the third stage, the immune system has become so damaged by HIV that symptoms
begin to appear. As a results, it leads to greater CD4+ cell destruction and the immune
system is not able to keep up with replacing the CD4+ cells that are lost. As the im-
mune system fails, symptoms start to develop, the reader is referred to Robertson [44].
Symptoms are typically mild at first, and then slowly become more severe. Opportunis-
tic infections, infections that take advantage of the immune system’s vulnerable state,
begin to occur. These infections affect almost all the systems of the body and include
both infections and cancers. Some common opportunistic infections include tuberculosis,
cytomegalovirus, and shingles. In this stage HIV infection is often characterized by by
multi-system disease and infections in almost all body systems. Treatment for a specific
infection or cancer is often carried out, however the main cause is the action of HIV as it
attacks the immune system. Unless HIV itself can be reduced, immune suppression will
continue to be weaker.
Stage 4: Acquired Immune Deficiency Syndrome
In the fourth and final stage, a person is diagnosed as having AIDS. The progression to
AIDS can be characterized by having a CD4+ count of 200 per ml or below, while the
normal situation is around 1000 per ml. At this stage, the infected individual is likely
to develop opportunistic infections in their respiratory system, gastro-intestinal system,
central nervous system and on the skin as well. Once a person is diagnosed with AIDS,
the AIDS status is permanent. For more information we refer you to Robertson [44].
A blood test can determine if a person is infected with HIV, but if a person tests positive
for HIV, it does not necessarily mean that the person has AIDS. A diagnosis of AIDS
is made by a physician according to the CDC AIDS Case Definition. A person infected
with HIV may receive an AIDS diagnosis after developing one of the CDC-defined AIDS
6
 
 
 
 
indicator illnesses. A person with HIV can also receive an AIDS diagnosis on the basis of
certain blood tests (CD4 counts) and may not have experienced any serious illnesses.
1.3 Treatment.
There is currently no publicly available vaccine or cure for HIV or AIDS. However, a
vaccine that is a combination of two previously unsuccessful vaccine candidates was re-
ported in September 2009 to have resulted in a 30 percent reduction in infections in a
trial conducted in Thailand, [56], [44], [57]. Additionally, a course of antiretroviral treat-
ment administered immediately after exposure, referred to as post-exposure prophylaxis,
is believed to reduce the risk of infection if begun as quickly as possible. In July 2010,
a vaginal gel containing tenofovir, a reverse trancriptase inhabitor, was shown to reduce
HIV infection rates by 39 percent in a trial conducted in South Africa.
However, due to the incomplete protection provided by the vaccine and/or post-exposure
prophylaxis, the avoidance of exposure to the virus is expected to remain the only re-
liable way to escape infection for some time yet. Current treatment for HIV infection
consists of highly active antiretroviral therapy or HAART. This has been highly benefi-
cial to many HIV-infected individuals since its introduction in 1996, when the protease
inhibitor-based HAART initially became available. Current HAART options are combi-
nations (or cocktails) consisting of at least three drugs belonging to at least two types,
or classes, of antiretroviral agents. Typically, these classes are two nucleoside analogue
reverse trancriptase inhibitors (NARTIs or NRTIs) plus either a protease inhibitor or a
non-nucleoside reverse transcriptase inhibitor (NNRTI) [56].
There is no empirical evidence for withholding treatment at any stage of HIV infection,
and death rates are almost twice as high when therapy is deferred (until the CD4 count
falls below 500) compared to starting therapy when the CD4 count is above 500. How-
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ever, the timing for starting HIV treatment is still subject to debate. The United States
Panel on Antiretroviral Guidelines for Adults and Adolescents in 2009 recommended that
antiretroviral therapy should be initiated in all patients with a CD4 count less than 350,
with treatment also recommended for patients with CD4 counts between 350 and 500.
However for patients with CD4 counts over 500, the expert Panel was evenly divided,
with 50 percent in favor of starting antiretroviral therapy at this stage of HIV disease,
and 50 percent viewing initiating therapy at this stage as optional. They noted that,
patients initiating antiretroviral therapy should be willing and able to commit to lifelong
treatment and should understand the benefits and risks of therapy and the importance of
adherence [21].
New classes of drugs such as entry inhibitor provide treatment options for patients who
are infected with viruses already resistant to common therapies, although they are not
widely available and not typically accessible in resource-limited settings. Because AIDS
progression in children is more rapid and less predictable than in adults, particularly in
young infants, more aggressive treatment is recommended for children than adults. In
developed countries where HAART is available, doctors assess their patients thoroughly:
measuring the viral load, how fast CD4 declines, and patient readiness. They then decide
when to recommend starting treatment [55], [57].
HAART neither cures the patient nor does it uniformly remove all symptoms. High
levels of HIV-1, often HAART resistant, return if treatment is stopped. Moreover, it
would take more than a lifetime for HIV infection to be cleared using HAART. Despite
this, many HIV-infected individuals have experienced remarkable improvements in their
general health and quality of life, which has led to a large reduction in HIV-associated
morbidity and mortality in the developed world. One study suggests the average life ex-
pectancy of an HIV infected individual is 32 years from the time of infection if treatment
is started when the CD4 count is 350/µL [56]. Life expectancy is further enhanced if
antiretroviral therapy is initiated before the CD4 count falls below 500/µL.
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In the absence of HAART, progression from HIV infection to AIDS has been observed
to occur at a median of between nine to ten years and the median survival time after
developing AIDS is only 9.2 months. However, HAART sometimes achieves far less than
optimal results, in some circumstances being effective in less than fifty percent of patients.
This is due to a variety of reasons such as medication intolerance or side effects, prior
ineffective antiretroviral therapy and infection with a drug-resistant strain of HIV. How-
ever, non-adherence and non-persistence with antiretroviral therapy is the major reason
most individuals fail to benefit from HAART.
The reasons for non-adherence and non-persistence with HAART are varied and overlap-
ping. Major psychosocial issues, such as poor access to medical care, inadequate social
supports, psychiatric disease and drug abuse contribute to non-adherence. The com-
plexity of these HAART regimens, whether due to pill number, dosing frequency, meal
restrictions or other issues along with side effects that create intentional non-adherence
also contribute to this problem. The side effects include lipodystrophy, dyslipidemia, in-
sulin resistance, an increase in cardiovascular risks, and birth defects.
Anti-retroviral drugs are expensive, and the majority of the world’s infected individuals do
not have access to medications and treatments for HIV and AIDS. Unfortunately, for now
the vaccine is considered to be able to halt the pandemic [56]. This is because a vaccine
would cost less, thus being affordable for developing countries, and would not require
daily treatment. However, after over 20 years of research, HIV-1 remains a difficult target
for a vaccine For more information we refer the reader to [44], [46], [57], [55].
1.4 HIV and AIDS public health education programs
The expansion and improvement of HIV and AIDS education around the world is critical
to preventing the spread of HIV. Effective HIV and AIDS education can help prevent new
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infections by providing people with information about HIV and how it is passed on, and
in doing so equip individuals with the knowledge to protect themselves from becoming
infected with the virus. HIV and AIDS education can take place in many different envi-
ronments, from classes at school to families and friends sharing knowledge at home. It is
important that this education is provided in a variety of settings to ensure that the most
vulnerable and marginalized groups in society are reached, and that accurate information
about HIV and AIDS is reinforced from different sources.
The most common place for people to learn about HIV and AIDS is at school. Due to
their capacity and universality, schools are a crucial setting for educating young people
about AIDS. As young people are at a high risk of becoming infected with HIV, it is vital
that they are educated about HIV transmission before they are exposed to situations that
put them at risk of HIV infection (for example, before they are sexually active). Schools
play a major role in shaping the attitudes, opinions and behavior of young people and so
are ideal environments for teaching the social as well as the biological aspects of HIV and
AIDS. Members of the wider community can also increase their knowledge about HIV and
AIDS through the school environment. Teachers who expand their understanding of the
subject while planning lessons and receiving teacher training can pass this information
on to adults as well as pupils, and the same can be said for children themselves; once
informed about AIDS, they can tell their parents or their friends what they have learned.
Educating people at work is an important way of providing people with vital prevention
information, and can reach people who have previously missed out on HIV and AIDS
education. Furthermore, it is estimated that nine out of ten people living with HIV are
working [44]. Providing education in the workplace is important for protecting those at
work living with HIV, and for helping them to live healthily and stay in work [55].
There are a great variety of methods and materials that can be used to educate people
about HIV and AIDS, including radio and television, booklets, billboards, comic strips,
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street theatre, AIDS fundraising events and many more. The form in which HIV and
AIDS education should be delivered depends on those who are being educated. In order
to reach the target group, it needs to be considered which environments they will be
most receptive in, and what media is most relevant to them. How HIV and AIDS educa-
tion should be delivered also depends on the principal aims of the education programme.
Sometimes education on HIV and AIDS is about giving people information which they
will remember on a long term basis, about how to protect themselves, the difference be-
tween HIV and AIDS, and helping to reduce discrimination. Other education strategies
are intended to have more immediate effects, and may target people when they are most
likely to take part in risky behavior i.e. in nightclubs or holiday resorts.
Mathematical models have become important tools in analyzing the spread and control
of infections diseases. For more details see Hethcote [22]. The model formulation process
clarifies assumptions, variables, and parameters. Moreover models provide conceptual
results such as thresholds, basic reproduction numbers, contact numbers and replacement
numbers. Understanding the transmission characteristics of infections diseases in commu-
nities, regions and countries can lead to better approaches to decreasing the transmission
of these diseases. Mathematical models are used in comparing, planning, implementing,
evaluating and optimizing various detection, prevention, therapy and control programs
[22].
The purpose of the dissertation is to find ways to stabilize HIV/AIDS. We have read that
the model of Cai et al. [12] allows some infected individuals to move from the symptomatic
phase to the asymptomatic phase by all sorts of treatment methods. In Chapter 3, we
reviewed a model taken from Nyabadza et al. [38]. The model of HIV/AIDS inspects the
decline in infection by supporting sexual behaviour change through public health informa-
tion campaigns and also by withdrawal of individual with AIDS from sexual behaviour.
We have investigated the basic reproduction number R0 (using the next generation ma-
trix) as a threshold parameter that determines whether a disease can invade a population
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and the equilibrium solution(i.e. the disease free equilibrium and the endemic equilib-
rium). We further introduce the global stability of a disease free equilibrium, followed by
simulations.
In chapter 4, we introduce a model taken from Bhunu et al. [7]. We formulate the basic
reproduction number, followed by some simulations. We examine how counseling and
testing coupled with a decrease in sexual activities could affect the HIV epidemic in re-
source limited communities. In chapter 5 we introduce our main model with the basic
reproduction number. We present the global stability of a disease free equilibrium and
the local stability of the endemic equilibrium. We further present the sensitivity analysis
of R0 and simulation. The optimal control has been formulated in Chapter 6 with simu-
lations. We finally introduce the stochastic HIV model using the paper of Cai et al. [12],
followed with simulations.
In these three models, we will investigate the role of public health campaigns by looking
at different behavior of the population. We use these three different approaches so that we
can see which model is more useful in regards to the stability of HIV/AIDS. In chapter
3 we will look at HIV/AIDS with education, followed by chapter 4, where we look at
the different sexual behavior of individuals with HIV/AIDS with education. Finally,
In chapter 5 we will look at the behavior of HIV/AIDS with treatment and education
included.
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1.5 Literature Review
During the development of epidemiology modeling in the population, deterministic (com-
partmental) models played a central role. These are the papers where the deterministic
model has been used [12], [34], [38], [24], [39], [40], [8], [54] and so on. Such models
divide the population into homogeneous sub-populations. The models that are labeled by
SI, SIS, SEIS, and SEIR are mostly used where the sub-populations are Susceptible,
Exposed, Infected and Recovered or Removed.
In [38], Nyabadza et al. looked at a model of HIV/AIDS that examine the diminution
in infection by promoting a change in sexual behavior through public health information
campaigns and individuals with AIDS to abstain from sexual activities. Both the endemic
and disease free equilibrium have been investigated. Numerical simulations are presented
using the fourth order of Runge-Kutta. The results from their research have shown that
media campaigns had led to a reduction in the prevalence of the disease but may not
be the only ultimate strategy in the fight against HIV/AIDS. It has also shown that an
increase in the distribution of public health information campaigns has lead to a decrease
in occurrence of a disease. In the case of the individual with AIDS abstaining from sexual
activities has also reduced the effect of the disease.
The impact of educational campaigns as a control measure for the spread of HIV/AIDS
has been investigated by Mukandavire et al. in [34]. The authors present a sexual trans-
mission model with explicit incubation period. Their results suggested that educating
sexually immature and sexually mature individuals concurrently is more effective in slow-
ing down HIV/AIDS than concentrating on cohort public health educational campaign of
sexually immature or sexually mature individuals only. It is shown that in their study, in
situations where education is effective and with with reasonable average number of HIV
infected partners, public health campaigns can slow down the epidemic.
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An epidemic HIV/AIDS model with treatment has been investigated in the paper by Cai
et al, see [12]. The model allows some infected individuals to move from symptomatic
phase to the asymptomatic phase by all kinds of treatments. The authors introduced the
time delay to the model in order to investigate the effect of the time delay on the stability
of the endemically infected equilibrium. This discrete time delay has also been used to
the model to describe the time from the start of the treatment in the symptomatic stage
until the treatment effects becomes clear. It was found that treatment can be used to
make the disease free equilibrium (E0) stable when it would be unstable in the absence of
treatment. On the other hand using the time delay can induce oscillation in the system.
Biologically, this means that there is a critical value for the treatment-induced delay which
determines the stability of the infected equilibrium E∗. That is, the infected equilibrium
E∗ is asymptotically stable when antiretroviral drugs on average show positive effects in
patients within less than time delay.
The HIV/AIDS epidemic in resource limited communities has been studied by Bhunu et
al. in [7]. The authors suggested in their research that effective conselling and testing
will be able to control the HIV/AIDS epidemic. Therefore, it was investigated that the
continuing increase of the HIV/AIDS in resource poor settings may be an indication of
poor counseling. The results show that educational programs regarding HIV/AIDS have
a positive impact in controlling the disease. They also suggested that giving free an-
tiretroviral drugs to HIV positive individuals who change their sexual behavior and have
withdrawn from sexual contacts may be an effective tool to control the epidemic.
A continuous model for HIV/AIDS disease progression has been formulated and physio-
logical interpretations were provided by Ida et al. in [24]. The abstract theory was then
applied to show existence of unique solutions to the continuous model describing the be-
havior of the HIV virus in the human body and its reaction to treatment by antiretroviral
therapy. The product formula has suggested appropriate discrete models describing the
dynamics of host pathogen interactions with HIV1 and is applied to perform numerical
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simulations based on the model of the HIV infection process and disease progression. Fi-
nally, the results of the numerical simulations are visualized and it was observed that the
results of Ida et al. [24] agreed with medical and physiological aspects.
A simple deterministic HIV/AIDS model incorporating condom use, sexual partner acqui-
sition, behavior change and treatment as HIV/AIDS control strategies has been formu-
lated by Nyabadza et al. in [39] using a system of ordinary differential equations with the
object of applying it to the current South African situation. The authors fit the model to
a data from UNAIDS/WHO on HIV/AIDS in South Africa and the epidemiological facts
sheets shows the current prevalence scenario. The results compare very well with other
research outcomes on the HIV/AIDS epidemic in South Africa. Projections were made
to track the changes in the number of individuals who were able to be under treatment,
an important group as far as public health planning is concerned.
Nyabadza and Mukandavire [40] formulated a deterministic HIV/AIDS model that in-
corporates condom use, screening through HIV counseling and testing(HCT). A regular
testing and treatment as control strategies has been proposed with the objective of quanti-
fying the effectiveness of HCT in preventing new infections and predicting the long-term
dynamics of the epidemic. The authors fit the model to a current prevalence data in
South Africa from UNAIDS/WHO reports and epidemiological fact sheet. They looked
at a recently launched HTC campaign to model its possible impact on the dynamics of
the disease. The model shows that HTC its self has a very little impact in reducing the
prevalence of HIV unless the ability of the campaign exceed an evaluated threshold in the
absence of bifurcation. The results has shown that force of infection can only be reduced
through behavior change, condom use and reduction in the number of sexual partners
and these form the pillars of prevention of new infection. The results has show that the
presence of bifurcation has an important implications in the control of HIV/AIDS. The
model in [40] has shown that it cannot be eliminated by simply reducing the value of
reproduction number R0 to below unity.
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In this paper Bhunu et al. [8] has considered a more robust systematic and complete
qualitative analysis of a two strain HIV/AIDS model with treatment of AIDS patients.
The treatment with amelioration results in an increase in number of HIV patient and
a decrease in Aids patients. Bhunu et al has advised that treatment with amelioration
should always be accompanied by public health education. The authors investigated that
if the drugs used for therapy are 100 percent effective and a positive change in the sexual
behavior of treated individuals is achieved, treatment with amelioration will not increase
the development of HIV/AIDS in societies but will help communities by lengthening the
lives of the infected, thus, reducing morbidity/mortality and socio-economic costs. Fur-
ther the analysis of the reproduction numbers show that the use of antiretroviral therapy
to improve the quality of life of AIDS patients with antiretroviral sensitive, HIV results in
an increase of antiretroviral resistant HIV cases supporting the argument that antiretro-
viral resistance develops as result of selective pressure on non-resistant strains due to
antiretroviral use.
A non-linear mathematical model has been propose and analyzed to study the spread
of HIV/AIDS with direct inflow of infective in a population with inconsistent volume
structure in [41]. Naresh et al [41] has looked at a model without inflow of HIV infec-
tive including interaction with pre-AIDS individuals and Model without inflow of HIV
infective and no interaction with pre-AIDS individuals. It was found that if the direct
inflow of the infective has been allowed in the community the disease always persist. The
endemicity is extensively reduced if direct inflow of infective is restricted and pre-Aids
individuals do not take place in sexual activities. Naresh et al suggested sexual partners
should be restricted and unsafe sexual iteration should be avoided with an infective in
order to reduce the spread of the disease. Thus the spread of infection can be slowed
down if direct inflow of infectives is restricted into the population. It was also noted that
the increase in the number of sexual partners further reduces the total population by way
of spreading the disease. Thus in order to reduce the spread of the disease, the number
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of sexual partners should be restricted and unsafe sexual interaction should be avoided
with an infective.
In the paper [54], Zurakowskia and Teel has proposed the interaction of the immune
system and human immunodeficiency virus where we will introduce the possibility of
using highly active anti-retroviral therapy (HAART) to stimulate the vaccine. They fur-
ther present a model predictive control (MPC) based method for determining optimal
treatment. Finally they analyze the simulations by using algorithms where they apply
robustness measurement noise, robustness modeling error, robustness combined errors,
and varying the cost function.
An SIR model with six compartments where there is an interaction between HIV and
TB epidemics has been investigated in [6]. They further look at sensitivity of the steady
states with respect to changes in parameter values. The authors examine that most of
the control measures studied have an obvious positive impact in controlling the HIV or
TB epidemics, this is the case for condom use, increased TB detection and preventive
treatment. The situation for ART is more complicated. However, although the future for
the prevalence of HIV is uncertain, it seems that a generalized access to ART would lead
to a significant decrease of the TB notification rate. They further concluded that it is
difficult to guess if the observations drawn from the model with parameters adapted to
the particular South African township are still valid for less crowded areas with high HIV
prevalence. finally reliable data on both HIV and TB are still rare.
In [35], Mukandavire and Garira formulated and analyzed a sex-structured model for het-
erosexual transmission of HIV/AIDS. The model has been further divided into two classes,
consisting of individuals involved in high-risk sexual activities and individuals involved in
low-risk sexual activities. The model is described as the movement of individuals from
high to low sexual activity group as a result of public health education campaigns. The
threshold parameter which is the basic reproduction number has been obtained and their
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stability (local and global) of the disease free equilibrium. The model has been extended
to incorporate sex workers, and their role in the spread of HIV/AIDS in settings with het-
erosexual transmission was explored. In order to assess the possible community benefits
of public health educational campaigns in controlling HIV/AIDS comprehensive analytic
and numerical techniques were employed. Mukandavire and Garira [35] concluded that
the presence of sex workers enlarges the epidemic threshold R0, thus fuels the epidemic
among the heterosexuals, and that public health educational campaigns among the high-
risk heterosexual population reduces R0, thus can help slow or eradicate the epidemic.
The models mentioned so far are deterministic and they do not consider the stochastic
disturbance of environment which exists in fact. When the environmental noise is not
taken into account, an ordinary differential equation is used for AIDS transmission for
instance. The introduction of stochastic modeling has provided new insights into the
population dynamics of the disease. We can refer to [17, 25, 29, 32, 52, 47]. In particular,
stochastic modeling of HIV/AIDS can be found by Ding et al. and Jiang et al. in [17, 25].
In the paper of Lahrouz et al. [29] they have formulated an SIRS epidemic model with
saturated incidence rate and disease-inflicted mortality. In the same paper, the authors
have further looked at the stochastic version. The global existence and positivity of the
solution of the stochastic system has been established. Under suitable conditions on
the intensity of the white noise perturbation, the global stability in probability and pth
moment of the system has been proved. In this regard, this dissertation refers mainly to
the papers [29, 50].
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Chapter 2
Mathematical tools
Epidemiology is the study of the distribution and determinants of diseases, for both
infectious and non-infectious diseases. Originally the term was used to refer only to the
study of epidemic infection diseases, but it is now applied more broadly to other diseases
as well. Mathematical models have become important tools in analyzing the spread
and control of infections diseases. The review paper [22] of Hethcote expands on this
point. The model formulation clarifies assumptions, variables, and parameters. Moreover
models provide conceptual results such as thresholds, basic reproduction numbers, contact
numbers and replacement numbers. Understanding the transmission characteristics of
infectious diseases in communities, regions and countries can lead to better approaches
to decreasing the transmission of these diseases. As explained in [22], mathematical
models are used in comparing, planning, implementing, evaluating and optimizing various
detection, prevention, therapy and control programs [22]. We introduce the following
definitions and theorems necessary to model the population dynamics of HIV/AIDS.
2.1 Epidemiological terminology
The prevalence of a disease is defined as the percentage of a particular population that
is infected with a disease. The incidence of a disease is the rate at which new infections
occur. Hence if the number of people infected with a particular disease at the start of
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a particular year is d, out of a population of size N , and n new infections occur over
the course of the year, then the prevalence rate at the start of the year is d
N
and the
annual incidence rate is n
N−d
. When the disease is introduced into a population, it usually
expands rapidly at first, with prevalence rate rising. In some cases the prevalence drops
to zero, but in many cases, prevalence stabilizes at a non-zero level that is referred to as
endemic prevalence.
2.2 Basic Linear Equation
The general first-order differential equation for the function y = y(x) is written as
.
y= f(x, y),
where f(x, y) can be any function of the independent variable x and dependent variable
y. For more information, the reader may consult the book [13] of Chasnov.
2.3 Invariant Region
A set M is an invariant set with respect to a system of ordinary differential equations
.
x= f(x) if
x(0) ∈M ⇒ x(t) ∈M, for all t ∈ R.
A set M is a positively invariant set with respect to
.
x= f(x) if
x(0) ∈M ⇒ x(t) ∈M, for all t ≥ 0.
2.4 Equilibrium
Definition 2.1.1 Given a system of differential equations
.
x= f(t), an equilibrium x∗ of
this system is a point in the state space for which X(t) = x∗ is a solution for f(t) = 0,
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for all t. For more detail see Allen [31].
Definition 2.1.2. [31].
(a) An equilibrium solution x of
.
X= F (X) is said to be locally stable if for each ǫ > 0
there exist a δ > 0 with the property that every solution X(t) of
.
X= F (X) with
initial condition X(t0) = X0 and
‖X0 − x‖ 2 < δ,
satisfies the condition that
‖Xt − x‖2 < ǫ
for all t ≥ t0. If the equilibrium is not locally stable it is said to be unstable.
(b) An equilibrium solution x is said to be locally asymptotically stable if it is locally
stable and if there exist γ > 0 such that
‖X0 − x‖2 < γ implies limt→∞ ‖X(t)− x‖2 = 0.
2.5 Routh-Hurwitz criteria
Consider the characteristic equation
Ωn + a1Ω
n−1 + a2Ω
n−2 + ...+ an−1Ω + an = 0
determining the n eigenvalues, Ω, of a real n× n square matrix A. Then the eigenvalues
Ω all have negative real parts if
H1 > 0, H2 > 0, H3 > 0, ...Hn > 0
where
21
 
 
 
 
Hn =
∣∣∣∣∣∣∣∣∣∣∣∣
a1 1 · · · 0
a3 a2
... 0
...
...
...
...
0 0 0 an
∣∣∣∣∣∣∣∣∣∣∣∣
.
The steady state is stable (that is, Re Ω < 0) for all λ if and only if Hj ≥ 0 for all
j = 1, 2, 3, ..., n, see Allen [31].
2.6 Linearization
Let (U∗, V ∗) be a steady state of
.
U= f(U, V ),
.
V= g(U, V ), (2.1)
so that f(U∗, V ∗) = g(U∗, V ∗) = 0. Let u = U − U∗ and v = V − V ∗. We assume that
we may neglect higher order terms if u and v are sufficiently small, and we obtain the
approximate (linearized) equations
.
u= fu(U
∗, V ∗)u+ fv(U
∗, V ∗)v, (2.2)
.
v= gu(U
∗, V ∗)u+ gv(U
∗, V ∗)v, (2.3)
or, defining the Jacobian matrix J(U, V ) in the usual way,
.
w= J∗w, (2.4)
where w is the column vector (u, v), and a star denotes the evaluation at the steady
state. The behavior of the system near (U∗, V ∗) depends on the eigenvalues of the matrix
J∗ = J(U∗, V ∗). It can be shown that the neglect of higher order terms is valid, and the
non-linear system behaves like a linear system near the steady state, as long as neither of
the eigenvalues of J∗ has zero real part.
Making the definitions β = trJ∗, γ = detJ∗, δ = discJ∗, the eigenvalue equation is
λ2 − βλ+ γ = 0, and we may determine the character of the steady state from the signs
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of these, see Britton[10]. We quote the theorem.
Theorem 2.4.1 (Steady states and eigenvalues) [10],
• If γ < 0, the (trivial) steady state of the second order system is at (2.4) is a saddle
point. Both eigenvalues are real one positive and one negative.
• If γ > 0, δ > 0, β < 0, it is a stable node. Both eigenvalues are real and negative.
• If γ > 0, δ > 0, β > 0, it is an unstable node. Both eigenvalues are real and positive.
• If γ > 0, δ < 0, β < 0, it is a stable focus. The eigenvalues are complex conjugate,
with negative real part.
• If γ > 0, δ < 0, β > 0, it is an unstable focus. The eigenvalues are complex
conjugates, with positive real part.
• If γ > 0, δ < 0, β = 0, it is a center. The eigenvalues are complex conjugates, and
purely imaginary.
Theorem 2.4.2 Linearization Theorem [10]. Let us suppose that the non-linear system
.
y= Y (y) (2.5)
have a simple fixed point at y = 0. Then, in a neighborhood of the origin, the phase
portraits of the system and its linearization are qualitatively equivalent provided the lin-
earized system is not at center [10].
Lemma 2.4.3 [48]. Suppose that x0 is a disease free equilibrium of a system
.
xi= fi(x) = Fi(x)− Vi(x), i = 1, . . . , n and fi(x)
satisfy the condition that if x ≥ 0, then
Fi, V
+
i , V
−
i ≥ 0 for i = 1, . . . , n.
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Through the condition that if F (x0) is set to zero, then all eigenvalues of Df(x0) have
negative real parts then derivatives DF (x0) and DV (x0) are partitioned as
DF (x0) =


F 0
0 0

, DV (x0) =


V 0
J3 J4

,
where F and V are the m×m matrix defined by
F =
(
∂Fi
∂xj
(x0)
)
, and V =
(
∂Vi
∂xj
(x0)
)
with 1 ≤ i, j ≤ m.
Further, F is nonnegative, then V is a nonsingular M-matrix and all eigenvalues of J4
have positive real part.
2.7 Liapunov stability
An important technique in stability theory for differential equations is one known as the
direct method of Liapunov. A Liapunov function is constructed to prove stability or
asymptotic stability of an equilibrium in a given region.
Definition 2.2.1. A positive-definite function V in an open neighborhood of the ori-
gin is said to be a Liapunov function for the autonomous differential system,
.
x= f(x, y),
.
y= g(x, y), if
.
V (x, y) ≤ 0 for all (x, y) ∈ U−(0, 0). If
.
V (x, y) < 0 for all (x, y) ∈ U−(0, 0),
the function V is called a strict Liapunov function.
Theorem 2.2.2 (Liapunov’s Stability Theorem [31].) Let (0,0) be an equilibrium of
the autonomous system
.
x= f(x, y) and let V be a positive definite C1 function in a
neighbourhood U of the origin.
1. If
.
V (x, y) ≤ 0 for all (x, y) ∈ U − (0, 0), then (0, 0) is stable.
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2. If
.
V (x, y) < 0 for all (x, y) ∈ U − (0, 0), then (0, 0) is asymptotically stable.
3. If
.
V (x, y) > 0 for some (x, y) ∈ U − (0, 0), then (0, 0) is unstable.
We note that in case 1 the function V is a Liapunov function and in case (2) V is a strict
Liapunov function.
2.8 Compound matrix
Let B be an n × n matrix. For more information we refer to Wang and Song [49]. The
second additive compound matrix of B, denoted by B[2], is an

 n
2

 ×

 n
2

 matrix.
For instance, if B = (bij) is a 3× 3 matrix, then
B[2] =


b11 + b22 b23 −b13
b32 b11 + b33 b12
−b31 b21 b22 + b33


.
2.9 Compartmental modelling
We explain the idea of a compartmental model by the way of a simple example. The
approach for modelling the transmission of infection disease in human populations is usu-
ally to subdivide the population under consideration into subpopulations or a number
of epidemiological classes called compartments and the resulting model is called a com-
partmental model. These compartments are defined with respect to disease status of an
individual. We can consider a standard model where the population is divided into three
classes such as Susceptible individuals, Infected individuals and a class of AIDS progressed
individuals. The population number in each class is represented as a function of time, by
S(t), I(t) and A(t) respectively.
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• Susceptible: Individuals who are not infected. They are able to catch the disease
and once they have contracted it they move to the infected compartment.
• Infected: Individuals who are are infected. It is assumed that they can spread the
disease to susceptible individuals.
• AIDS class: Individuals who are infected and show AIDS related symptoms.
The number of susceptible individuals can increase due to newly recruited individuals,
while the number can decrease due to new infections as a results of interaction with in-
fected individuals in class I(t) and also due to natural death. Infected individuals who
joined the class I(t) can progress to A(t) or may die due to natural death. After progres-
sion to A(t), individuals are removed from this class due to natural or disease induced
death.
The total sexually mature population at a given time is the sum of individuals in all
classes, and is given by
P (t) = S(t) + I(t) + A(t).
We describe the parameters as follows, The term µN is the recruitment rate per unit
time into the susceptible class and µ is the average death rate by natural causes. The
parameter c represents the rate of sexual contacts of an infected individual with susceptible
individuals per unit time. The parameter β is the probability of infecting per effective
contact and α is the rate of progression of infected individuals to AIDS class per unit
of time. The term ν is the disease induced death rate of individuals in AIDS class per
unit of time. The following model has been taken from the paper of Ejigu [18]. Similar
models can be found in papers of [53], [27], [23], [31]. We will have the following system
of equations:
dS(t)
dt
= µN − cβS(t)I(t)
N(t)
− µS(t),
dI(t)
dt
=
cβS(t)I(t)
N(t)
− (µ+ α)I(t), (2.1)
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dA(t)
dt
= αI(t)− (µ+ ν)A(t).
Depending on the disease or the level of sophistication we want to reach, more classes
may be introduced.
2.10 The basic reproduction number
The basic reproduction number is sometimes referred to as a ratio. It is one of the most
useful threshold parameters or invariants, which characterize mathematical properties
concerning infectious disease models [12], [22], and [43]. It is widely used in mathemat-
ical epidemiology models. The analysis of the model includes finding equilibrium points
(steady states) of the model, finding the basic reproduction number R0 and investigating
the stability of the equilibrium points (disease-free and endemic equilibrium) which will
be characterized using the invariant R0.
Definition 2.2.1 The Basic Reproduction Number or Basic Reproduction Ratio is de-
fined as the average number of secondary infections that are produced when one infected
individual is introduced into a group of susceptible individuals. For more information see
Allen [31], Van den Driessche and Watmough [48].
It is implicitly assumed that the infected outsider is in the host population for the en-
tire infectious period and mixes with the host population in exactly the same way that
a population native would mix. The basic reproduction number R0 turns out to be the
threshold quantity that determines whether a disease can invade a population. If R0 < 1,
then on average an infected individual produces less than one new infected individual over
the course of its infectious period, and the infection cannot grow. Conversely, if R0 > 1
then each infected individual produces, on average, more than one new infection, and the
disease can invade the population [43].
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We obtain the equilibria of the system (2.1) by setting the time derivatives in the equations
to be equal to zero. The equilibrium point at Se = N and Ie = Ae = 0 represents a disease
free equilibrium. The endemic equilibrium is as follows
Se = (µ+ α)
N
β
,
Ie =
µN
β
[R0 − 1].
We notice that since the model has one infected compartment, then we can obtain R0 by
following the definition, the rate of transmission multiply by the infection period. The
parameter β is the rate of transmission and the infectious period is
1
µ+ α
.
Thus
R0 = β
1
µ+ α
=
β
µ+ α
.
However, for more complicated models with several infected compartments the definition
of R0 is not sufficient to calculate R0. The basic reproduction number R0 can be deter-
mined using the method of next-generation matrix as presented in Van den Driessche and
Watmough [48]. When we have more than one infected compartment we will use the next
generation matrix to find the basic reproduction number.
2.11 The next generation matrix
The next generation method introduced by Van den Driessche and Watmough [48], is a
general method of findingR0 in a case where we have more than one infected compartment.
Suppose we have n disease compartments and m non-disease compartments, and let x ∈
R
n and y ∈ Rm be subpopulations in each of these compartments. We denote the rate of
secondary infection increase of the ith disease compartment by Fi and Vi the rate disease
28
 
 
 
 
progression, death and recovery decrease the ith compartment. Thus we have the following
compartmental model:
dxi
dt
= Fi(x, y)− Vi(x, y), i = 1, ..., n,
dyi
dt
= gj(x, y), j = 1, ...,m,
The calculation of the basic reproduction number is based on linearization of the ordinary
differential equation (ODE) model about a disease free equilibrium, while the following
assumption ensure the existence of the equilibrium and well-posedness of the model.
• Assume Fi(0, y) = 0 and Vi(0, y) = 0 for all y ≥ 0 and i = 1, ..., n. All new
infections are secondary infections arising from infected host, there is no immigration
of individuals into the disease compartments.
• Assume Fi(0, y) ≥ 0 for all non-negative x and y and i = 1, ..., n. The function F
represents new infections and can not be negative.
• Assume Vi(0, y) ≤ 0 whenever xi = 0, i = 1, ..., n. Each component, Vi represents a
net outflow from compartment i and must be negative (inflow only) whenever the
compartment is empty.
• Assume∑ni=1 Vi(x, y) ≥ 0 for all non-negative x and y. This sum represent the total
outflow from all infected compartments. Terms in the model leading to increase in∑n
i=1 xi are assumed to represent secondary infections and therefore belong in F.
• Assume the disease free system dy
dt
= g(0, y) has a unique equilibrium that is asymp-
totically stable. That is, all solution with initial conditions of the form (0, y) ap-
proach a point (0, y0) as t → ∞. This point is referred to as the disease free equi-
librium.
Now assuming that Fi and Vi meet the above conditions, we can form the next generation
matrix FV −1 from matrices of partial derivatives of Fi and Vi. Now we have
F =
[∂Fi(x0)
∂xj
]
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and
V =
[∂Vi(x0)
∂xj
]
,
where i, j = 1, ...,m and where x0 is the disease free equilibrium. The entries of FV
−1
give the rate at which infected individuals in xj produce new infections in xi, times the
average length of time an individual spends in a single visit to compartment j. R0 is given
by the spectral radius (dominant eigenvalue) of the matrix FV −1.
If the basic reproduction number is less than unity i.e., R0 < 1 then the disease-free
equilibrium is locally asymptotically stable, which implies that the disease will die out in
the population. On the other hand, if the reproduction number is greater than unity, then
the endemic equilibrium is locally asymptotically stable. The technique used to determine
the stability of the equilibrium points for complex models will be shown in the following
Chapters.
2.12 Staged Progression of HIV model
The staged progression model has a single uninfected compartment and infected individ-
uals progress through several stages of the disease with changing infectivity. This model
is applicable to many diseases, mainly HIV/AIDS, where transmission probabilities vary
as the viral load in an infected individual changes. For more information see [48], and it
has been applied in [18], [38]. Thus we have the following model:
I
′
1 =
m−1∑
k=1
βkSIk
N
− (ν1 + d1)I1,
I
′
i = νi−1Ii−1 − (ν1 + d1)Ii, i = 2, ...,m− 1,
I
′
m = νm−1Im−1 − dmIm,
S
′
= b− bS −
m−1∑
k=1
βkSIk
N
. (2.6)
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The model assumes standard incidence, death rate di > 0 in each infectious stage, and the
final stage has a zero infectivity due to morbidity. Infected individuals spend on average,
1
vi
time units in stage i.
Thus we have the following basic reproduction number from the model (2.6):
R0 =
β1
ν1 + d1
+
β2ν1
(ν1 + d1)(ν2 + d2)
+
β3ν1ν2
(ν1 + d1)(ν2 + d2)(ν3 + d3)
+ ...+
βm−1ν1...νm−2
(ν1 + d1)...(νm−1 + dm−1)
.
The i′th term in R0 represents the number of new infections produced by a typical indi-
vidual during the time it spends in the i′th infectious stage. More specifically, νi−1
(νi−1+di−1)
is the fraction of individuals reaching stage i − 1 that progress to stage i, and 1
νi+di
is
the average time an individual entering stage i spends in stage i. Hence, the i′th term
in R0 is the product of the infectivity of individuals in stage i, the fraction of initially
infected individuals surviving at least to stage i, and the average infectious period of and
individual in stage i.
2.13 Optimal control method
Optimal control theory has been used as a very powerful mathematical tool to make
decisions involving complex biological situations and it has been derived from the calculus
of variations. Optimal control techniques are of great use in developing optimal strategies
to control various kinds of diseases. For more information, consult the book of Lenhart and
Workman [30]. It has been used, for instance, in finding the percentage of the population
that should be vaccinated as time evolves in a given epidemic model to minimize the
number of infected and the cost of implementing the vaccination strategy.
The behavior of a dynamic system is described by the state variable(s). We assume that
there is a way to control the state variable(s) x, by acting upon it with a suitable control.
We noticed that the dynamic system (state x) depends on the control u. The goal is
to adjust the control u in order to minimize or maximize a given objective functional,
J(u(t), x(t), t), that attains the desired goal, and the required costs to achieving it. The
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optimal control is obtained when the desired goal is achieved with the least cost. The
functional depends on the control and the state variables. There are a number of different
methods for calculating the optimal control for a specific model. Pontryagin Maximum
Principle for example allows the calculation of the optimal control for an ordinary dif-
ferential equations model system with given constraints. See the book of Lenhart and
Workman [30].
The following are characteristics that an optimal control problem may exhibit
• Controllability: ability to use controls to steer a system from one position to another.
• Observability: deducing system information from control input and observe output.
• Stabilization: implementing controls to force stability.
The principal technique for the optimal control problem is to solve a set of necessary
conditions, that an optimal control and corresponding state must satisfy. It is important
to understand the logical difference between necessary conditions and the sufficient con-
ditions of solution sets.
Let us considering the optimal control problem of the form below.
Determine
min
u
{
φ(tf , x(tf )) +
∫ tf
0
g0(t, x(t), u(t))dt
}
where
f(x(t)) = [x1(t), x2(t), ..., xns(t)]
T ∈ Rn
is the state vector and
u(t) = [u1(t), u2(t), u3(t), ..., unc(t)]
T ∈ Rm
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is the control vector.
The state and the control variables are governed by the dynamics described by a set of
first order differential equations:
dx
dt
= f(t, x(t), u(t)) x0 = x(0), 0 ≤ t ≤ tf (2.3)
The functions:
f(h0) : T × Rn × Rm → Rn
f(g0) : T × Rn × Rm → Rn
are continuously differentiable with respect to each component of x and u, and piecewise
continuous with respect to t.
2.14 Pontryagin’s Maximum Principle
The Pontryagin’s Maximum Principle converts the maximization or minimization of the
objective functional J , coupled with the state variable into pointwise maximizing or min-
imizing of the Hamiltonian with respect to the control. The Hamiltonian H(t, x, u, λ) is
a function of four variables. Time t is the underlying variable for each of x, u and λ is a
function of t, called the adjoint variable.
Theorem 2.2.3. [30] If u∗(t) and x∗(t) are optimal for problem (2.3), then there exists
a piecewise differential adjoint variable λ(t) such that
H(t, x∗(t), u(t), λ(t))≤H(t, x∗(t), u∗(t), λ(t))
for all controls u at each time t, where the Hamiltonian H is
H = f(t, x(t), u(t)) + λ(t)g(t, x(t), u(t))
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and
λ(t)
dt
= −∂H(t, x
∗(t), u∗(t), λ(t))
∂x
,
λ(tf ) = 0.
Necessary conditions: If u∗(t) and x∗(t) are optimal, then the following conditions
hold:
λ(t)
dt
= −∂H(t, x
∗(t), u∗(t), λ(t))
∂x
,
λ(tf ) = 0,
∂H(t, x∗(t), u∗(t), λ(t))
∂u
= 0.
Sufficient conditions: If u∗(t), x∗(t) and λ(tf ) satisfy the following conditions
λ(t)
dt
= −∂H(t, x
∗(t), u∗(t), λ(t))
∂x
,
λ(tf ) = 0,
∂H(t, x∗(t), u∗(t), λ(t))
∂u
= 0,
then u∗(t) and x∗(t) are optimal.
2.15 Sensitivity analysis
Sensitivity analysis is used to determine the relative importance of model parameters to
disease transmission. We perform the analysis by calculating the sensitivity indices of
the basic reproduction number, R0, because it determines whether or not the infectious
disease will spread in the population. Sensitivity analysis is commonly used to determine
the robustness of model predictions to parameter values, since there usually errors in data
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collection and pre-assumed values. It also allows for the measurement of relevant changes
in a state variable when a parameter changes.
In performing the sensitivity analysis, we apply the method called normalized forward
sensitivity index of a variable that has been used quite commonly, and it is defined as
the ratio of relative change in the variable to the relative change in the parameter. The
sensitivity may also be defined using partial derivatives when the variable is a differentiable
function of the parameter.
Definition: The normalized forward sensitivity index of an invariant, J , that depends
on a parameter, k, is defined as :
rJ0k :=
∂J0
∂k
× k
J0
.
2.16 Brownian Motion
Brownian motion refers to the ceaseless, irregular random motion of small particles im-
mersed in a liquid or gas, as observed by R. Brown in 1827. The phenomenon can be
explained by the perpetual collisions of the particles with the molecules of the surround-
ing medium. The stochastic process associated with the Brownian motion is called the
Brownian process or the Wiener process. The concept has found application in a wide
range of fields. So for instance, Brownian motion has become one of the fundamental
building blocks of modern quantitative finance. Indeed, the basic continuous time model
for financial asset prices assumes that the log-return of a given financial asset follow a
Brownian motion with drift. There are also interesting applications of Brownian motion
to epidemiology. For more information the reader may consult Mao, [33].
Definition: Let (Ω,F , P ) be a probability space with filtration {Ft}t≥t0 . A one dimen-
sional Brownian motion is a real valued continuous {Ft} adapted process {Bt}t≥t0 with
the following properties:
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(i) B0 = 0 almost surely;
(ii) for 0 ≤ s < t < ∞, the increment Bt − Bs is normally distributed with mean zero
and variance t− s;
(iii) for 0 ≤ s < t <∞, the increment Bt −Bs is independent of {Fs} ;
(vi) Bt is continuous in t ≥ 0.
We refer the reader to the book of Mao, [33].
2.17 The multi-dimensional Itoˆ’s formula
Let x(t) be a d-dimensional Itoˆ’s process on t ≥ 0 with the stochastic differential [33], i.e.,
a stochastic process of the form
dx(t) = f(t)dt+ g(t)dB(t),
where f ∈ L1(R+;Rd) and g ∈ L2(R+;Rd×m). Then any V (x(t), t) is again an Ito’s process
with the stochastic differential given by
dV (x(t), t) =
[
Vt(x(t), t) + Vx(x(t), t)f(t) +
1
2
trace(gT (t)Vxx(x(t), t)g(t))
]
+ Vx(x(t), t)g(t)dB(t). a.s.
Note that
dtdt = 0, dB(ti)dt = 0, dBidBi = dt, dBidBj = 0 if i 6= j. (2.7)
2.18 Stability in probability theory
Consider the general n-dimensional stochastic system
dx(t) = f(t, x(t))dt+ g(t, x(t))dB(t) (2.8)
on t ≥ 0 with initial value x(0) = x0. The solution is denoted by x(t, x0). Assume that
f(t, 0) = g(t, 0) = 0 for all t ≥ 0, so the origin point is an equilibrium of (2.8) The
equilibrium x = 0 of the system (2.8) is said to be:
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(i) Stable in probability if for all ǫ > 0,
lim
x0→0
P
(
sup
t≥0
|x(t, x0)| ≥ ǫ
)
= 0;
(iv) Almost surely exponentially stable if for all x0 ∈ Rn
lim
x0→0
sup
1
t
ln |x(t, x0)| < 0 a.s.;
We refer the reader to a paper of Lahrouz et al., [29].
2.19 Differential Operator
We define the differential operator L associated with the following equation:
dx(t) = f(x(t), t)dt+ g(x(t), t)dB(t) t ≥ t0,
by
L =
∂f(x(t), t)
∂t
+
d∑
i=1
f(x, t)
∂
∂xi
+
1
2
d∑
i,j=1
[
g(x, t)gT (x, t)
]
i,j
∂2
∂xi∂xj
.
If L acts on a function of V ∈ C2,1(Sh × R+;R+), then
LV = Vt(x, t) + Vx(x, t) +
1
2
trace
[
gT (x, t)Vxx(x, t)g(x, t)
]
,
where Vt =
∂V
∂t
, Vx =
(
∂V
∂x1
, ..., ∂V
∂xd
)
, Vxx =
(
∂2V
∂xi∂xj
)
d×d
. For more information the reader
may consult the book of Mao, [33].
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Chapter 3
A 4-compartment model of HIV
with Education
Public health information campaigns and withdrawal of individuals with AIDS from sex-
ual activities has been investigated in Nyabadza et al. [38]. The model for HIV/AIDS
incorporates HIV prevention using mass media campaigns and withdrawal of individuals
with AIDS. The model was revisited in [1]. In the paper of [1], the focus was on control
and sensitivity of an HIV model with public health education. In this Chapter we offer
a discussion of the work in [38]. In particular we use a Lyapunov function to prove the
global stability, an original contribution, now included in [1]. We also contributed in this
model by running some simulation.
All parameters of the model are assumed to be positive. Using the model of Nyabadza
[38], the recruitment rate of susceptible individuals is given by µK and µ is the per capita
natural death rate of individuals in all classes. The transfer rate from the asymptomatic
compartment to the symptomatic compartment is given by σ. The parameter ρ is the pro-
gression rate of infected individuals from I2 to A and δ represent the per capita disease
induced death per unit time. The parameter c is the contact rate of susceptible individ-
uals with infected individuals and β is the probability of infection. The effectiveness of
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information as it spreads in preventing HIV transmission in an environment with public
health HIV/AIDS information campaigns is quantified by parameter α. Susceptible are in-
fected with HIV following unprotected sexual contact with an infected individual at a rate
λ(I, A). The proposed contact rate is set to depend on the number of infected individuals
in the population, which is of the form cβg(I,A)
ψ(I,A)
, where g(I, A) = I1(t)+η1I2(t)+η2(1−q)A
and ψ(I, A) = 1 + αg(I, A). We thus have the following system of equations:
S
′
(t) = µK − µS − λ(I, A)S,
I
′
1(t) = λ(I, A)S − (µ+ σ)I1,
I
′
2(t) = σI1 − (µ+ ρ)I2,
A
′
(t) = ρI2 − (µ+ δ)A, (3.1)
where
λ(I, A) =
cβ(I1 + η1I2 + η2(1− q)A)
1 + α(I1 + η1I2 + η2(1− q)A) ,
η1 and η2 measure the relative infectivity of I2 and A, when compared to I1 and I =
(I1 + I2). We assume that all parameters are positive and the initial conditions of the
model system (1) are as follows:
S(0) = S0 > 0, I1(0) = I10 > 0, I2(0) = I20 > 0, and A(0) = A0 > 0.
3.1 Invariant region
The system in model (3.1) describes a human population, and hence we need to be sure
that the solution S(t), I1(t), I2(t) and A(t) of the model (3.1) remain non-negative all
the time. In other words, solutions of model (3.1) with given non-negative initial data re-
main positive all the time and bounded in a region G. Thus we have the following Lemma.
Lemma 3.1. [38] The region G defined by
G =
{
(S(t), I1(t), I2(t), A(t)) ∈ R4+ : N ≤ K
}
,
is positively invariant and attracting with respect to model system (3.1).
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3.2 Disease free equilibrium
Now, we study equlibria of the model. We have found the disease free equilibrium S =
K, I1 = 0, I2 = 0 and A = 0, by equating the time derivative on the LHS in system (3.1)
to be equal to zero, simplifying and solving the equations simultaneously. Thus we have
the following theorem.
Theorem 3.2. The model given by the system (3.1) has a unique feasible disease free
equilibrium given by
E0 = (S0, I1, I2, A0) = (K, 0, 0, 0).
It can be checked easily by using system (3.1).
3.3 Basic reproduction number
The analysis of the model includes finding equilibrium points of the model, finding the
threshold value, basic reproduction number R0 and investigate the stability of the equi-
librium points (disease-free and endemic which will be characterized using the threshold
value R0). The basic reproduction number has already been calculated in [38], and we
will just supply some details here. We will use the method used of Van den Driessche and
Watmough [48], to find the basic reproduction number of the model. The basic reproduc-
tion number is defined in Chapter 2. It is important to note that R0 is a dimensionless
number and not a rate, which would have units of time−1. Since we have more than one
infected compartment, we will use the next generation matrix method.
Thus we have
F=


cβK cβη1K cβη2K(1− q)
0 0 0
0 0 0


40
 
 
 
 
and
V=


µ+ σ 0 0
−σ µ+ ρ 0
0 −ρ (µ+ σ)(µ+ ρ)


.
By using the adjoint method we have the following inverse:
V −1 = 1
(µ+σ)(µ+ρ)(µ+σ)


(µ+ ρ)(µ+ σ) 0 0
σ(µ+ δ) (µ+ σ)(µ+ δ) 0
σρ 0 (µ+ σ)(µ+ ρ)


.
The reproduction number is given by the spectral radius (dominant eigenvalue) of the
matrix FV −1, denoted by ρ(FV −1). Thus,
ρ(FV −1) =
cβK
µ+ σ
[
1 +
η1σ
µ+ ρ
+
η2σρ(1− q)
(µ+ ρ)(µ+ δ)
]
,
where
R1 =
cβK
µ+ σ
,R2 =
cβη1K
(µ+ ρ)(µ+ σ)
and
R3 =
cβη2K
(µ+ δ)(µ+ ρ)(µ+ σ)
,
represents the contribution of the asymptomatic, symptomatic and AIDS individuals to
the overall model reproduction number R0 respectively.
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3.4 Endemic equilibrium
Theorem 3.4. [38] If R0 > 1, the model given in (3.1) has a unique endemic equilibrium
point given by
E∗ = (S∗, I∗1 , I
∗
2 , A
∗),
given by the following:
S∗ =
(σ + µ)(αµ+ βcΓ + αµ(R0 − 1))
βcΓ(αµ+ βcΓ)
,
I∗1 =
µ(R0 − 1)
αµ+ βcΓ
,
I∗2 =
σµ(R0 − 1)
(ρ+ µ)(αµ+ βcΓ)
,
A∗ =
ρσµ(R0 − 1)
(ρ+ µ)(δ + µ)(αµ+ βcΓ)
. (3.1)
3.5 Global stability of E0
We now establish the global stability of the disease free equilibrium. The following result
forms part of the paper [1].
Theorem 3.6. The disease-free equilibrium E0 of the model (3.1) is globally asymptoti-
cally stable in G if R0 < 1.
Proof. Let us first fix the following constants a1, a2, a3 and ξ, a1 = (mu + ρ)(µ + δ),
a2 = Kcβ[η1(µ+ δ)] + ρξ], a3 = ξKcβ(µ+ ρ), where ξ = η2(1− q).
Now we define the following function V = V (I1(t), I2(t), A(t)), which we shall prove to be
a Lyapunov function at the point (I1, I2, A) = (0, 0, 0).
V = a1I1 + a2I2 + a3A.
Then
V
′
= a1I
′
1 + a2I
′
2 + a3A
′
.
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Now noting that S(t) < K for all t and λ < cβ(I1 + η1I2 + ξA),
it follows that we can write:
.
V < Q1I1 +Q2I2 +Q3A,
where the coefficients Qi have the following values:
Q1 = a1[cKβ − (µ+ σ)] + a2σ,
Q2 = a1η1cKβ − a2(µ+ ρ) + a3ρ,
Q3 = a1ξcKβ − a3(µ+ δ).
Now we notice that when substituting the values of a1, a2, a3 and ξ, we obtain the follow-
ing:
Q2 = a1η1cKβ − cKβ[η1(µ+ δ) + ξρ](µ+ ρ) + a3ρ
= a1η1cKβ − a1η1cKβ − cKβρξ(µρ) + cKβξ(µ+ ρ)ρ
= 0
Likewise, for Q3 we find:
Q3 = ξcKβ(mu+ ρ)(µ+ δ)− ξcKβ(mu+ ρ)(µ+ δ)
= 0.
Finally we turn to Q1.
Q1 = a1cKβ + a2σ − a1(µ+ σ)
= (µ+ σ)
[
cKβ
(µ+ σ)
+
a2σ
a1(µ+ σ)
− 1
]
= (µ+ σ)
[
cKβ
(µ+ σ)
+
cKβ[η1(µ+ δ) + ρξ]σ
(µ+ ρ)(µ+ δ)(µ+ σ)
− 1
]
= a1(µ+ σ)
[
cKβ
µ+ σ
{
1 +
η1σ
µ+ ρ
+
ρξσ
(µ+ rho)(µ+ δ)
}
− 1
]
= (µ+ ρ)(µ+ δ)(µ+ σ)[R0 − 1]
≤ 0,
since R0 ≤ 1. It follows that V is a Lyapunov function as asserted.
This completes the proof. 
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Figure 3.1: Variation of the HIV/AIDS population of the model system 3.1.
3.6 Numerical Simulation
To study the behavior of system (3.1) numerically, a forth order Runge-Kutta scheme is
used. We consider a hypothetical population of one million sexually active individuals
at time t = 0. An annual increase of 49,300 individuals was assumed in the paper of
Nyabandza et al. [37]. We consider the numerical simulations that illustrates the theorem
on the stability of disease free and endemic equilibrium. In Figure 3.1(a) the simulation
illustrates the variation of S, I1, I2, and A with time whenever R0 < 1. For the case of
R0 > 1 it is shown in figure 3.1(b). In Cai et al. [12] symptomatic individuals are assumed
to have a lower rate of infection when compared to the asymptomatic individuals. In this
model we however assume that symptomatic individuals have a higher viral load and are
thus more infectious, since viral load affects infection rate. The higher the viral load the
higher the likelihood of infection. The probability of β may vary considerably. We thus
consider 1 ≤ η1, η2 ≤ 2 in our simulations. The death rate due to the disease is chosen
to be 0.33 per year. The parameter values have been taken form Nyabadza et al. [38].
Table 3.1 summarizes all the parameters used in the simulations.
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Table 3.1: Model parameters and their interpretations
Parameter description Parameter Estimated value
Recruitment rate µK 0.05
Proportion of withdrawals by AIDS cases q 0.5
Rate of becoming symptomatic σ 0.18
Natural death rate µ 0.02 ≥ µ ≥ 0.03
Exposure rate to media campaigns α 1
Rate of developing AIDS ρ 0.06
Probability of transmission β 0.02
Partner acquisition rate c 1.5
Enhancement factors η1 1.6
Enhancement factors η2 1.8
Disease-induced death rate σ 0.18
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Figure 3.2: Deterministic trajectories of the HIV/AIDS population dynamics of the model
system 3.1
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Figure 3.3: Variation of the HIV/AIDS population dynamics of the model system 3.1
when: R0 = 0.4 in (g) and (i) and R0 = 1.5 in (h) and (j).
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Chapter 4
A 6-compartmental model of HIV
model with education
The paper of Bhunu et. al. [7] presents a model of HIV/AIDS in which the classes are
separated according to their HIV status and sexual activity levels, and which accommo-
dates the effect of HIV/AIDS education programs. The entire population is divided into
the following compartments:
• S : the susceptibles.
• I1 : the individuals who are HIV positive and do not know their status.
• I2 : the individuals who are HIV positive and know their status and reduce their
risky sexual behavior as a result of knowing their status.
• I3 : the individuals who are HIV positive and know their status and have increase
in risky sexual behavior as a result of knowing their status.
• I4 : HIV positive individuals who are sexually inactive.
• A : AIDS patients.
It is assumed that sexually inactive HIV positive individuals are no longer contributing
new infections. Their total abstinence from sexual activities may be due to some of the fol-
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lowing: effective public health education and HIV/AIDS information campaigns, a variety
of sexual abstinence education programs, sexual isolation of individuals by some sexual
means, individuals moral and religious reasons such as church, culture. We contributed
in this model by means of simulations.
Thus the population size N(t) is given by:
N(t) = S(t) + I1(t) + I2(t) + I3(t) + I4(t) + A(t).
Based on the fact that the infectious period is very long (≥ 10 years), we cannot regard
the population size as staying constant. The model is described by the following system
of equations:
S
′
(t) = Λ− (λ+ µ)S,
I
′
1(t) = λS − (µ+ ρ+ δ)I1,
I
′
2(t) = fδI1 − (µ+ θ + ρ)I2,
I
′
3(t) = (1− f)δI1 − (µ+ θ + ρ)I3,
I
′
4(t) = θ(I2 + I3)− (µ+ ρ)I4,
A
′
(t) = θ(I1 + I2 + I3 + I4)− (µ+ ν)A. (4.1)
Here λ is the rate at which susceptible individuals get infected with HIV, and
λ =
βc(I1(t) + φ1I2(t) + φ2I3(t))
N
.
Thus, β is the probability of getting infected per sexual contact, the parameter c is
the effective contact rate. The parameter φ1 ∈ (0, 1) models of the effect of a positive
behavioral change as a result of knowing one’s HIV positive status while φ2 > 1 accounts
for increase in risky behavior as a result of knowing one’s HIV positive status. After
infection with HIV, susceptible individuals infected with HIV will move into the class
of HIV infected people not knowing their status (I1). Individuals in the class (I1) will
know their HIV status through testing at a rate δ and counseling. A proportion f of HIV
positive people knowing their status will move into the class I2 and the complementary
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(1− f) will move onto the class I3, respectively. HIV positive individuals who know their
status will move into the sexually inactive class I4 at a rate θ. For simplicity, we assume
the same θ value in both I2 and I3 classes. HIV positive people in classes I1, I2, I3 and I4
progress to the AIDS class (A) at a rate ρ. In all classes individuals experience natural
death at a constant rate µ which is proportional to the number in each class. Individuals
in the AIDS class have an additional disease-induced death rate ν.
4.1 Disease-free equilibrium
The definition of a disease-free equilibrium has been stated in Chapter 2, so it follows
that the model has the following disease-free equilibrium, E0,
E0 = (
Λ
µ
, 0, 0, 0, 0, 0).
4.2 Basic reproduction number
By the method used in the previous section, due to Van den Driessche and Walmough
[48], the basic reproduction number of the model (4.1) is calculated in [7] and is given by
R0 = R1 +R2 +R3, (4.2)
where
R1 =
cβ
µ+ ρ+ δ
, R2 =
cβfφ1δ
(µ+ θ + ρ)(µ+ ρ+ δ)
and
R3 =
cβδφ2(1− f)
(µ+ θ + ρ)(µ+ ρ+ δ)
.
The numbers R1, R2 and R3 can be considered to represent the average number of infected
individuals as a contribution of each class I1, I2 and I3 respectively.
The term cβ
µ+ρ+δ
represents the new infections caused by infected individuals in the first
stage I1, where
1
µ+ρ+δ
is the average time that infected individuals spend in the first stage
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before progressing to the second stage or before dying due to natural causes.
The second term of R0,
fφ1
µ+ρ+δ
represents the fraction of individuals who progressed from
stage one and are aware of their status (with presumed change of risky sexual behavior
through abstinence or otherwise). The term, cβ
µ+θ+ρ
represents the new infections caused
by the infected individuals in the second stage.
The last term, cβ
µ+θ+ρ
, represents the number of new infections from infected individuals
at the third stage, (1−f)φ2
(µ+θ+ρ)
is the proportion of individuals progress to the third stage
who adopt risky sexual behavior and δ
µ+ρ+δ
represents a proportion of those who receive
education, its effect is to reduce R0. The term,
1
µ+θ+ρ
signifies the average time an infected
individual will stay in the third stage.
Thus we have
R0 =
cβ(µ+ ρ+ θ + (fφ1 + (1− f)φ2)δ)
(µ+ ρ+ θ)(µ+ δ + ρ)
.
4.3 Endemic equilibrium
Theorem 3.5. If R0 > 1, the model given in (4.1) has a unique endemic equilibrium
point given by
E∗ = (S∗, I∗1 , I
∗
2 , I
∗
3 , I
∗
4A
∗),
given by the following:
S∗ =
Λ
µ
− (µ+ ρ+ δ)Λ(R0 − 1)(µ+ ν)(µ+ ρ)
µ(µ++θ + ρ)((µ+ ρ+ δ)[(µ+ ρ)(µ+ ν)R0 − ρν]) ,
I∗1 =
Λ(R0 − 1)(µ+ ν)(µ+ ρ)
(µ+ ρ+ δ)[(µ+ ρ)(µ+ ν)R0 − ρν] ,
I∗2 =
fδΛ(R0 − 1)(µ+ ν)(µ+ ρ)
(µ+ θ + δ)((µ+ ρ+ δ)[(µ+ ρ)(µ+ ν)R0 − ρν]) ,
I∗3 =
(1− f)δΛ(R0 − 1)(µ+ ν)(µ+ ρ)
(µ+ θ + δ)((µ+ ρ+ δ)[(µ+ ρ)(µ+ ν)R0 − ρν]) ,
I∗4 =
θδΛ(R0 − 1)(µ+ ν)(µ+ ρ)
(µ+ θ + δ)((µ+ ρ+ δ)[(µ+ ρ)(µ+ ν)R0 − ρν]) ,
A∗ =
ρΛ(R0 − 1)
(µ+ ρ)(µ+ ν)R0 − ρν .
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4.4 Numerical Simulations
In this chapter, we will look at how can we numerically solve the system (4.1) using the
fourth order of scheme Runge-Kutta. We will use the parameters in table 4.1 to numeri-
cally examine the effect of varying abstinence rate for the model in system (4.0.1). Figure
4.1(a) shows the effect of counseling and testing alone as an intervention approach as well
as the combination of abstinence on HIV/AIDS disease. In figure 4.1(b), the graph illus-
trates what happens when there is a disease free equilibrium. It shows that the population
growth is not affected by the disease as there will be in infection in the population. In
figure 4.1(c), the graph denotes when HIV/AIDS exist in the population where counseling
coupled with abstinence exist. In figure 4.1(d) and (e) shows when HIV/AIDS exist in
the population where counseling and testing is the only strategy, as these simulations
suggest that counseling and testing alone is not enough in the fight against the epidemic.
In figure 4.1(f) shows a situation where HIV/AIDS exist in the abstinence of any public
health campaign.
In these graphs, we note that in countries where the resources are limited when more
people getting to know their status they increase the risky sexual behavior as a results
of knowing their status. This tends to suggest that the epidermic is being influenced
by people who know their status and have a negative change. We therefore suggest
that public health health campaign programs are very important in reducing the effect of
HIV/AIDS. We also suggest that counseling and testing with abstinence must also include
the treatment in order to bring down the viral load of HIV/AIDS. The parameter have
been taken from Bhunu et al. [7].
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Table 4.1: Model parameters and their interpretations
Parameter description Parameter Estimated value
Recruitment rate Λ 0.029
Natural mortality rate µ 0.02
Rate of knowing one’s HIV status σ 0.1
through counseling and testing
Natural rate rate of progression to AIDS ρ 0.1
Modification parameter φ1 0.25
Modification parameter φ2 1.01
Proportion reducing risky sexual behavior f 0.85
as a result of knowing their HIV status
AIDS related death rate ν 0.333− 0.4
Product of effective contact rate for βc 0.011− 0.95
HIV infection and probability of HIV
transmission per contact
Abstinence rate θ 0.2
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Figure 4.1: Variation of the HIV/AIDS population dynamics of the model system 4.1
when R0 = 0.15.
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Figure 4.2: Variation of the HIV/AIDS population dynamics of the model system 4.1
when R0 = 0.025 in (g) and R0 = 1.5 in (h), (i), (j), (k) and (l).
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Figure 4.3: Variation of the HIV/AIDS population dynamics of the model system 4.1
when R0 = 1.5 in (m) and (n).
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Chapter 5
An HIV model with treatment and
education
Based on the model of Cai et al. [12], which already includes treatment, we develop a
model of HIV/AIDS that takes into account the effect of public health education. Our
model is of the compartmental type and the population is divided into the four compart-
ments which are the susceptible class (S), infectious classes that is for the asymptomatic
phase (I), the symptomatic phase (J) and the AIDS patients class (A). Thus the total
population is given by
N(t) = S(t) + I(t) + J(t) + A(t). (5.1)
When susceptible individuals make sufficient contact with individuals in one of the other
stages, new infections will result. All the newly infected individuals will join the asymp-
tomatic stage. The individuals will stay in the asymptomatic phase or will progress to
J-class if the symptoms are showing. They may die due to natural causes at each stage
at a rate µ. They will then move to A class and this means full-blown AIDS with disease
induced mortality.
The parameters used in this model are: µK the recruitment rate of sexually matured indi-
viduals into a susceptible class, c the contact rate of susceptible individuals with infected
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individuals, µ the per-capita natural death rate of individuals in all classes, irrespective
of being susceptible or infected. The factor β is the probability of disease transmission
per contact by an infective in the first stage. The factor bβ is the probability of disease
transmission per contact by an infective in the second stage. Furthermore, k1 and k2 are
the transfer rate constants from the asymptomatic stage I to the symptomatic stage J
and from the symptomatic stage to the AIDS cases, respectively. The factor α is the
transfer rate rate from the symptomatic stage J to the asymptomatic stage I and δ is the
disease related death rate of the AIDS cases. Suppose that public health information and
education programs result in reduction of the coefficients c, k1, and k2 by the amounts
ǫ0, ǫ1, ǫ2, respectively. Thus the term u denotes the education campaign effort. We assume
maximum values: ǫ0u ≤ c, ǫ1u ≤ k1, ǫ2u ≤ k2.
The resulting system of equations is given by:
dS
dt
= µK − βS(I + bJ)(c− ǫ0u)− µS,
dI
dt
= βS(I + bJ)(c− ǫ0u)− (µ+ k1 − ǫ1u)I + αJ,
dJ
dt
= (k1 − ǫ1u)I − (µ+ k2 − ǫ2u+ α)J,
dA
dt
= (k2 − ǫ2u)J − (µ+ δ)A. (5.2)
5.1 Basic reproduction number
The basic reproduction number of our model (5.2) can be deduced from that of the model
of Cai et al. [12]. Nevertheless we give the complete calculation. Since we have more
than one infected compartment we will use the next generation matrix to find the basic
reproduction number.
To calculate R0 we first arrange the system (5.2) as follows,
dI
dt
= βS(I + bJ)(c− ǫ0u)− (µ+ k1 − ǫ1u)I + αJ,
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dJ
dt
= (k1 − ǫ1u)I − (µ+ k2 − ǫ2u+ α)J,
dS
dt
= µK − βS(I + bJ)(c− ǫ0u)− µS.
The system (5.2) can be written as
x
′
= F (x)− V (x)
which implies that
x
′
i = Fi − Vi, x
′
i = Fi − (V −i − V +i ).
Thus F and V are the m×n matrix given by
F =
(
∂Fi(x0)
∂xj
)
, V=
(
∂Vi(x0)
∂xj
)
where Fi= the rate of appearance of new infections in compartment i,
V −i = the rate of transfer of individuals out of compartment i,
V +i = the rate of transfer of individuals out of compartment i.
From the system (5.2), Fi = βS(I + bJ)(c− ǫ0u),
F=


∂Fi
∂I
∂Fi
∂J
0 0

 =

 βS(c− ǫ0u) βbS(c− ǫ0u)
0 0


and
V=


∂V
∂I
∂V
∂J
∂V
∂I
∂V
∂J

 =


V1 −α
−k1 − ǫ1u V2 + α


where, for i ∈ {1, 2} , Vi = µ+ ki − ǫiu.
Thus we have F and V at the disease-free equilibrium E0 respectively.
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From the system (5.2), we have
F=


βK(c− ǫ0u) βbK(c− ǫ0u)
0 0


and
V=


V1 −α
−(k1 − ǫ1u) V2 + α


at the disease-free equilibrium E0.
Therefore FV −1 is the next generation of matrix of system (5.2), where
V −1 = (k1−ǫ1u)
(µ+k1−ǫ1u)(µ+k2−ǫ2u+α)−α


V2 + α α
(k1 − ǫ1u) V1


Thus
FV −1=


βK(c− ǫ0u) βbK(c− ǫ0u)
0 0




(V2+α
P
α
P
(k1−ǫ1u)
P
V1
P


where P = V1(V2 + α)− α(k1 − ǫ1u).
Thus FV −1 is the next generation of system (5.1). It follows that the spectral radius of
matrix FV −1 is given by
ρ(FV −1) =
βK(c− ǫ0u)(V2 + α + b(k1 − ǫ1u))
V1V2 + µα
.
Therefore R0 = ρ(FV
−1) is the threshold quantity, called the basic reproduction number
for the system (5.2) and is also called the spectral radius of the matrix FV −1.
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5.2 The disease free equilibrium
IfR0 < 1, the model given by the system (5.2) has a unique feasible disease free equilibrium
given by,
E0 = (K, 0, 0, 0). (5.3)
5.3 The endemic equilibrium
In addition to the disease-free equilibrium the model given (5.2) has a unique endemic
equilibrium point given by
E∗ = (S∗, I∗, J∗, A∗), (5.4)
which we calculate as follows
βS(c− ǫ0u)[(µ+ (k2 − ǫ2u) + α
(k1 − ǫ1u) )J + bJ ]
−(µ+ (k1 − ǫ1u))(µ+ (k2 − ǫ2u) + α)
(k1 − ǫ1u) J + αJ = 0
⇒ βSJ(c− ǫ0u)
(k1 − ǫ1u) [(µ+ (k2 − ǫ2u) + α) + b(k1 − ǫ1u)]
=
J
(k1 − ǫ1u)(µ+ (k1 − ǫ1u))(µ+ (k2 − ǫ2u) + α)− α(k1 − ǫ1u) = 0
βS(c− ǫ0u) = (µ+ (k1 − ǫ1u))(µ+ (k2 − ǫ2u) + α)− α(k1 − ǫ1u)
µ+ (k2 − ǫ2u) + α + b(k1 − ǫ1u)
S∗ =
(µ+ (k1 − ǫ1u))(µ+ (k2 − ǫ2u) + α)− α(k1 − ǫ1u)
β(c− ǫ0u)(µ+ (k2 − ǫ2u) + α + b(k1 − ǫ1u))
S∗ =
(µ+ (k1 − ǫ1u))(µ+ (k2 − ǫ2u) + µα)
β(c− ǫ0u)(µ+ (k2 − ǫ2u) + α + b(k1 − ǫ1u)) .
From the first equation of (5.2) we have the following solution:
I∗ =
(µ+ (k2 − ǫ2u) + α)µK
(µ+ (k1 − ǫ1u))(µ+ (k2 + αµ))(1−
1
R0
).
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The third equation of the system (5.2) gives
J∗ =
(k1 − ǫ1u)
(µ+ k2 − ǫ2 + α)I
∗.
By solving the forth equation of (5.2) we have the following:
A∗ =
(k2 − ǫ2u)
µ+ δ
J∗.
The endemic equilibrium is given by E∗ = (S∗, I∗, J∗, A∗). 
5.4 Stability of disease free equilibrium
5.4.1 Global stability of E0
In this section, we will now look at the global stability of the disease free equilibrium. We
will use the Lyapunov function to prove the global stability of the disease free equilibrium.
Theorem 5.1.1 If R0 ≤ 1, then the disease free equilibrium of the model given in (5.2)
is globally asymptotically stable in the feasible domain.
Proof. We define the Lyapunov function
L =
1
2
[(K − S) + I + J + A]2 + [µ+ (k2 − ǫ2u) + α
+ b(k1 − ǫ1u)]I + b[µ+ (k1 − ǫ1u) + α]J.
We obtain the following derivative of L
L
′
= [(K − S) + I + J + A] d
dt
[−S + I + J + A]
+ [(µ+ (k2 − ǫ2u) + α + b(k1 − ǫ1u))cβS
− ((µ+ (k1 − ǫ1u))(µ+ (k2 − ǫ2u) + αµ))](I + bJ)
= [(K − S) + I + J + A]
[
2βS(I + bJ)(c− ǫ0u)− µK + µS − µI
− µJ − δA− µA
]
+
[
(µ+ (k2 − ǫ2u) + α + b(k1 − ǫ1u))cβS
− ((µ+ (k1 − ǫ1u))(µ+ k2 − ǫ2u) + αµ))
]
(I + bJ)
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L
′
= [(K − S) + I + J + A]
[
2βS(I + bJ)(c− ǫ0u)− µ[(K − S)
+ I + J + A]− δA
]
+
[
(µ+ (k2 − ǫ2u) + α + b(k1 − ǫ1u))cβS
− ((µ+ (k1 − ǫ1u))(µ+ k2 − ǫ2u) + αµ))
]
(I + bJ).
By writing L
′
in terms of basic reproduction number, we have
L
′
= −[(K − S) + I + J + A]δA−
[
(K − S)
+ I + J + A
][
[µ((K − S) + I + J + A)]− 2βS(I + bJ)(c− ǫ0u)]
+ [(µ+ (k1 − ǫ1u)(µ+ (k2 − ǫ2u)) + αµ)
]
(R0 − 1)(I + bJ)
If R0 ≤ 1, then L′ ≤ 0. We note that, L′ = 0 if and only if S = K, I = J = A = 0 and
this completes the proof. 
5.4.2 Local Stability of E∗
Lemma 5.1.2 Let M be a 3 × 3 real matrix. If both tr(M) and det(M[2]) are negative,
then all the eigenvalues of M have negative real parts.
Theorem 5.1.3 The positive equilibrium E∗ of system (5.2) is locally asymptotically
stable if R0 > 1. [12]
Proof. By evaluating the Jacobian of the system (5.2) at the endemic equilibrium, we
get
∂f
∂x
(E∗) =


(wv+αµ)I∗
(v+α)S∗
− µ −βS∗(c− ǫ0u) −bβS∗(c− ǫ0u)
(wv+αµ)I∗
(v+α)S∗
βS∗(c− ǫ0u)− w bβS∗(c− ǫ0u) + α
0 k1 − ǫ1u −(v + α)


(5.1)
where w = µ+ k1 − ǫ1u, v = µ+ k2 − ǫ2u and
β(I∗ + bJ∗)(c− ǫ0u) = (wv+αµ)I
∗
(v+α)S∗
.
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Thus, we have the second additive compound of (5.1) as follows
∂f [2]
∂x
(E∗) =


−µ− (wv+αµ)I∗
(v+α)S∗
+ S∗l − w bS∗l + α bS∗l
k1 − ǫ1u −µ− (wv+αµ)I
∗
(v+α)S∗
− v − α S∗l
0 (wv+αµ)I
∗
(v+α)S∗
S∗l − w − v − α


By Lemma 5.1.2 above it is sufficient to prove that tr(∂f
∂x
E∗), det(∂f
∂x
E∗), and det(∂f
2
∂x
E∗)
are negative.
It follows from w > βS∗(c− ǫ0u) that
tr(
∂f
∂x
)(E∗) = −µ− (wv + αµ)I
∗
(v + α)S∗
+ βS∗(c− ǫ0u)− w − v − α < 0.
Computing for the determinant of the system (5.2) we obtain the following
det(
∂f
∂x
(E∗)) = −(wv + αµ)I
∗
(v + α)S∗
(v + α + k1 − ǫ1ub)βS∗(c− ǫ0u).
Also, the determinant of ∂f
[2]
∂x
(E∗) is as follows
det
∂f [2]
∂x
(E∗) = −(v + α + w − βS∗(c− ǫ0u))
[
(µ+
(wv + αµ)I∗
(v + α)S∗
)2
+(µ+ (wv + αµ)I∗(v + α)S∗)(w − βS∗(c− ǫ0u))
]
− (v + α)2[µ+ (wv + αµ)I
∗
(v + α)S∗
]− µ[w − βS∗(c− ǫ0u)](v + α)
− [ (wv + αµ)I
∗
(v + α)S∗
]×
[
βS∗(c− ǫ0u)((µ+ (wv + αµ)I
∗
(v + α)S∗
))
+ w − βS∗(c− ǫ0u)
]
− [α(k1 − ǫ1u)(wv + αµ)I
∗
(v + α)S∗
] < 0.
We note that if R0 > 0, then w − βS∗(c− ǫ0u) > 0. Thus det ∂f [2]∂x (E∗) < 0.
This completes the proof of Lemma 3.4.3. 
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Figure 5.1: Deterministic trajectories of the HIV/AIDS population dynamics of the model
system (5.2).
5.5 Numerical Simulation
In this section we present some numerical simulations for the system in (5.2) using the
fourth order Runge-Kutta. We numerically analyze the effect of public health campaign
for the model (5.2) using parameters described in Table (5.1). To illustrate the various
theoretical results presented in system (5.2), various values of β are used. In Figure 5.1(a),
5.2(c), (e) and 5.3(g), (e), illustrates the dynamic behavior of the SIJA model described
by the deterministic system (5.2) when R0 < 1. In Fig 5.1(b), 5.2(d), (f), and 5.3 (h),
(j), illustrates the dynamic behavior of the SIJA model described by the deterministic
system (5.2) when R0 > 1.
5.6 Sensitivity Analysis of R0
The basic reproduction number is pivotal in determining the stability of the disease free
equilibrium. It is thus important for us to understand the behavior of R0 with respect
to the different parameters it depends on. Sensitivity indeces allow us to measure the
relative change in a state when a parameter changes. The normalized forward sensitivity
index of a variable to a parameter is the ratio of the relative change in the variable to
the relative change in the parameter. When the variable is a differentiable function of the
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Figure 5.2: Deterministic trajectories of the HIV/AIDS population dynamics of the model
system (5.2) when R0 = 0.67 in (c) and (e) and when R0 = 1.3 in (d) and (f).
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Figure 5.3: Deterministic trajectories of the HIV/AIDS population dynamics of the model
system (5.2) when R0 = 0.67 in (g) and (i) and when R0 = 1.3 in (h) and (j).
67
 
 
 
 
Table 5.1: Model Parameters and their interpretations
Parameter Parameter description Estimated value
µ Natural death 0.02
rate of individuals
k2 Transfer rate constant 0.02
k1 Transfer rate constant 0.01
c Contact rate of 3
susceptible individuals
β Probability of 0.0005
disease transmission
K Recruitment rate 120
u Educational campaign effort 0.008
b Probability of 0.3
disease transmission
ǫ1 Reduced Coefficient 0.008
ǫ2 Reduced Coefficient 0.009
α Treatment rate 0.01
ǫ0 Reduced Coefficient 0.3
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parameter, the sensitivity index may be alternatively defined using partial derivatives.
We now derive the sensitivity of R0 to each of the twelve different parameters described
in Table 4.1
Let v = µ + (k1 − ǫ1u), w = µ + (k2 − ǫ2u), a = βK(c − ǫ0u) and b1 = µ + α + b(k1 −
ǫ1u) + (k2 − ǫ2u)
∂R0
∂µ
× µ
R0
=
µ[(vw + µα)− (2µ+ α + (k1 − ǫ1u) + k2 − ǫ2u)]
b1(vw + µα)
∂R0
∂c
× c
R0
=
c
c− ǫ0u
∂R0
∂b
× b
R0
=
b(k1 − ǫ1u)
µ+ α + (k2 − ǫ2u) + b(k1 − ǫ1u)
∂R0
∂ǫ0
× ǫ0
R0
= − ǫ0u
c− ǫ0u
∂R0
∂β
× β
R0
= 1
∂R0
∂K
× K
R0
= 1
∂R0
∂ǫ1
× ǫ1
R0
= −ǫ1[bu(vw + µα) + b1(µu+ ǫ1k2)]
b1(vw + µα)
∂R0
∂ǫ2
× ǫ2
R0
= −ǫ2u[(vw + µα) + b1(ǫ1u− µ− k1)]
b1(vw + µα)
∂R0
∂α
× α
R0
=
α(vw + µα)− µαb1
b1(vw + µα)
∂R0
∂k1
× k1
R0
=
k1[b(vw + µα)− (µ+ (k2 − ǫ2u))]
b1(vw + µα)
∂R0
∂k2
× k2
R0
=
k2[(vw + µα)− (µ+ (k1 − ǫ1u))]
b1(vw + µα)
∂R0
∂u
× u
R0
=
−bKuǫ0
a
− u(ǫ2 + bǫ1)
b1
+
u(µ+ k1ǫ2 + ǫ1µ+ k2ǫ1 − 2ǫ1ǫ2u)
vw + µα
The parameters shown in Table 5.2 are arranged from the most sensitive to the least from
the given base of the parameters as in the list. The most sensitive parameter is the contact
rate, c, the probability of disease transmission, β and the recruitment rate, K. The other
important parameter include probability of disease transmission, b, reduced coefficient ǫ1
and the treatment rate α. The least sensitive parameter is the natural death of individuals,
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Table 5.2: Sensitivity indices of R0
Parameter Parameter description Estimated value Sensitivity index
c Contact rate of 3 +1.000800641
susceptible individuals
β Probability of 0.0005 +1
disease transmission
K Recruitment rate 120 +1
b Probability of 0.3 +0.056338454
disease transmission
ǫ1 Reduced Coefficient 0.008 +0.00219750
α Treatment rate 0.01 +0.000456769
ǫ0 Reduced Coefficient 0.3 −0.000800641
ǫ2 Reduced Coefficient 0.009 −0.000183805
u Educational campaign effort 0.008 −0.366116685
k1 Transfer rate constant 0.01 −5.351471481
k2 Transfer rate constant 0.02 −7.732353411
µ Natural death 0.02 −21.25684921
rate of individuals
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µ. The sensitive index of R0 with respect to the probability of disease transmission β is
+1, implying that decreasing (or increasing) the β by 10 percent decreases (or increases)
R0 by 10 percent. Similarly increasing (or decreasing) the natural death rate of individuals
µ by 10 percent, increases (or decreases) the R0 by 212.57 percent.
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Chapter 6
Optimal public education campaign
We now search for optimal rollout of the public education campaign, in terms of how
much effort (or funding) to apply as a function of time. Thus in our model (5.2) we will
consider u to be time dependent. i.e., u = a(t). We want to see the classes I and J being
as small as possible, and we want to balance that with the public education campaign
effort. Thus we may want to consider a quantity of the form
u2(t) +m1I(t) +m2J(t)
to be somehow kept as small as possible, for some balancing weight constants m1 and m2.
Taking u in squared form is to ensure convexity of the problem. For more information
see the book of Lenhart and Workman [30]. Let us consider a time horizon [0, T ],
let
V (u(t)) =
∫ T
0
u2(t) +m1I(t) +m2J(t)dt. (6.1)
Thus we shall seek to solve the following optimal control problem,
Problem (6.1.1.):
Minimize V (u(t)) subject to the conditions (5.2), and the initial conditions
S(0) = S0 ≥ 0, I(0) = I0 ≥ 0, J(0) = J0 ≥ 0, A(0) = A0 ≥ 0, (6.2)
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and terminal conditions
S(T ), I(T ), J(T ) and A(T ) (6.3)
are free, while the control variables is assumed to be bounded above,
0 ≤ u(t) ≤ α ≤ 1. (6.4)
The Hamiltonian for this problem is given by
H(t, S, I, J, A, λ1, λ2, λ3, λ4) = u
2 +m1I +m2J + λ1
.
S +λ2
.
I +λ3
.
J +λ4
.
A
H(t, S, I, J, A, λ1, λ2, λ3, λ4) = u
2 +m1I +m2J
+ λ1(µK − βS(I + bJ)(c− ǫ0u)− µS)
+ λ2(βS(I + bJ)(c− ǫ0u)
− (µ+ k1 − ǫ1u)I + αJ)
+ λ3((k1 − ǫ1u)I − (µ+ k2 − ǫ2u+ α)J)
+ λ4((k2 − ǫ2u)J − (µ+ d)A)
Theorem 2.1.3 Let S∗, I∗, J∗, A∗ and u∗ be optimal solutions for the optimal control
problem (6.1), (6.2), (6.3) and (6.4). Then the costate variables satisfy the following
differential equations:
dλ1(t)
dt
= λ1β(I + bJ)(c− ǫ0u) + µλ1 − λ2β(I + bJ)(c− ǫ0u)
dλ2(t)
dt
= −m1 + λ1βS(c− ǫ0u)− λ2βS(c− ǫ0u) + (µ+ k1 − ǫ1u)
− λ3(k1 − ǫ1u)
dλ3(t)
dt
= −m2 + λ1βbS(c− ǫ0u)− λ2βbS(c− ǫ0u) + λ2α + λ3(µ+ k2 − ǫ2u)
−λ4(k2 − ǫ2u)
dλ4(t)
dt
= λ4(µ+ d) (6.5)
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with transversality conditions
λ1(T ) = 0, λ2(T ) = 0, λ3(T ) = 0 and λ4(T ) = 0.
and the optimal control takes the form
u∗(t) = min
[
max
(
βSǫ0(I + bJ)(λ2 − λ1) + ǫ1I(λ2 + λ3) + ǫ2J(λ4 − λ3)
2
, 0
)
, α
]
. (6.6)
Proof. We will use the Pontryagin maximum principle. For more information see Lenhart
and Workman [30]. We calculate partial derivatives of the Hamiltonian with respect to
the different state variables in order to obtain the time derivative λi of costate variables.
Since S(T ), I(T ), J(T ) and A(T ) are free, the following terminal conditions hold:
λ1(T ) = 0, λ2(T ) = 0, λ3(T ) = 0 and λ4(T ) = 0.
We start by examining,
dλ4(t)
dt
= −∂H
∂A
= (µ+ d)λ4,
integrating both sides we get,
λ4 =Me
(µ+d)t,
for some constantM . The terminal condition λ(T ) = 0, forcesM to disappear. Therefore
λ4 is equal to zero i.e., λ4 ≡ 0. We now calculate the following:
dλ1(t)
dt
= −∂H
∂S
,
dλ2(t)
dt
= −∂H
∂I
,
dλ3(t)
dt
= −∂H
∂J
,
and obtain the equations stated in the theorem.
The function u∗ must optimize H.
Thus we have,
∂H
∂u
= 2u+ λ1βS(I + bJ)ǫ0 − λ2(βS(I + bJ)ǫ0 + ǫ1I) + λ3(ǫ2J − ǫ1I)− λ4(ǫ2J).
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Now if
2u+ λ1βS(I + bJ)ǫ0 − λ2(βS(I + bJ)ǫ0 + ǫ1I) + λ3(ǫ2J − ǫ1I)− λ4(ǫ2J) = 0
for some values of [0, α] then the given value of u is optimal.
If for every value of u ∈ [0, α] we have
2u+ λ1βS(I + bJ)ǫ0 − λ2(βS(I + bJ)ǫ0 + ǫ1I) + λ3(ǫ2J − ǫ1I)− λ4(ǫ2J) ≥ 0,
2u+ λ1βS(I + bJ)ǫ0 − λ2(βS(I + bJ)ǫ0 + ǫ1I) + λ3(ǫ2J − ǫ1I)− λ4(ǫ2J) ≤ 0)
then we must choose u = 0 (respectively, u = α).
Thus we must have
u∗(t) = min
[
max
(
βSǫ0(I + bJ)(λ2 − λ1) + ǫ1I(λ2 + λ3) + ǫ2J(λ4 − λ3)
2
, 0
)
, α
]
.
The function u∗1(t) also must optimize H, and by a similar argument we obtain the definite
expression for u∗1(t). This completes the proof. 
6.1 Numerical simulation for the Optimal Control
The optimality system is solved using an iterative method of Runge-Kutta forth order
scheme. We note that in fig 6.1(a) the numerical results show that the number of suscep-
tible individuals increase after the optimal control treatment and public health education
campaign, leading to a smaller number of infected individuals. Fig 6.1(b), represents the
population of infected individuals without optimal control treatment and public health
educational programs, we observe that that the population is sharply increasing than the
individuals with control. This shows that we need treatment and public health educa-
tional campaign to control the infected individuals. In fig 6.1(c), we note that the infected
individual are decreasing due to optimal control treatment and public health educational
campaigns. Fig 6.1(d) shows that there is a decrease of AIDS individuals due to the
optimal control treatment and education that was implemented. The of the numerical
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Figure 6.1: Plot of the HIV/AIDS population dynamics of the model (5.1) using optimal
control strategies.
simulation shows that there is a small number of infected than before the optimal con-
trol. Thus we conclude that the rate of infected individuals decreases after the control
treatment and public health education campaign.
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Chapter 7
A stochastic HIV model
In this Chapter we study a Stochastic Differential Equation model of the HIV epidemic.
The main results, Theorem 7.3, is on almost sure exponential stability and is included in
the manuscript [1].
7.1 Types of models
The presence of stochastic perturbation in nature makes it desirable at times to introduce
random variables into the modeling. Stochastic models assume that the response vari-
ables are a family of random variables indexed by time so that the epidemic is basically a
stochastic process. Stochastic epidemic models are useful for small populations, possibly
of isolated communities, in which the known heterogeneity inherent in the population
is of importance. There are three different methods for formulating stochastic epidemic
models that relate directly to their deterministic counterparts. The three popular types of
stochastic modeling processes are described: discrete time Markov chain (DTMC) model,
Continuous time Markov chain (CTMC) model and stochastic differential equation (SDE)
model. These stochastic methods differ in the underlying assumptions regarding the time
and the state variables. For more information the reader may consult Allen [4]
In a DTMCmodel, the time and the state variables are discrete. For example, let S(t), I(t)
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and R(t) denote discrete time stochastic process for the number of susceptible, infected
and immune at time t, respectively. In a DTMC epidemic model, t ∈ 0,∆t, 2∆t, . . . and
the discrete random variable satisfy
S(t), I(t), R(t) ∈ {0, 1, 2, . . . , N} .
In a CTMC model, time is continuous, but the state variable is discrete. For example
given t ∈ [0,∞), and the state S(t), I(t) and R(t) are discrete random variable, i.e.,
S(t), I(t), R(t) ∈ {0, 1, 2, . . . , N} .
Finally, the SDE model is based on a diffusion process, where both the time and the
state variables are continuous. In our model we will use the SDE approach. It has been
applied in various papers, such as [29] by Lahrouz et al., [15] by Dalal et al., [17] by
Ding et al. and [51] by Yang et al. The paper [26] of Jovanovic´ and Krstic´ presents a
stochastic model of vector-borne diseases. We have also looked at some of the models in
which a stochastic perturbation has been inserted to each of the differential equations in
the system and these models are [32] by Lu, [52], [25] and [26]. We also have found that
there are instances where stochastic perturbation are introduced in such a way that the
total population size is still a deterministic function of time and such models are found
in [20] by Gray et al., [29] by Lahrouz et al. and [47] by Tornatore et al. We note that
for systems of stochastic differential equations, different versions of stability are defined
and studied in the literature. We refer to the book [33] of Mao and several papers, for
instance, [17], [52], [25], [20], [29] and [47].
One of the most important differences between the deterministic and stochastic epidemic
models is their asymptotic dynamics. It may happen that eventually stochastic solutions
(sample paths) converge to the disease-free state even though the corresponding determin-
istic solution converges to an endemic equilibrium. For stochastic differential equations in
general, this phenomenon is discussed in Mao’s book [33] for instance. Other properties
that are unique to the stochastic epidemic models include the probability of an outbreak,
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the quasistationary probability distribution, the final size distribution of an epidemic and
the expected duration of an epidemic.
7.2 A Stochastic differential equation model
Let us consider the model of Cai et al. [12] modified. Let us assume (Ω,F , {Ft}t≥t0 , P )
be a complete probability space which is right continuous with a filtration {Ft}t≥t0 . Let
B(t) be a one-dimensional Wiener process defined on this probability space. Let g(S, I, J)
be some function to be specified at a later stage. There are different ways of introducing
randomnes into epidemic models, see the paper of [11] for a survey. For example, a discrete
stochastic epidemic model is proposed in the paper [2] of Andersson and Lindenstrand
to study the probability of outbreaks. An approximation of the discrete model by a
system of stochastic differential equations is utilized to study the time to extinction of
the disease. In this paper we study an epidemiological population model which can be
described by a system of stochastic differential equations. For now let us refer to this form
of randomness as stochastic perturbation with independent processes. In other cases, a
stochastic perturbation is introduced in such a way that the total perturbation on the
system is zero see the paper of Lahrouz et al. [29]. This type will be said to have stochastic
perturbation with complementary processes. Thus we have the following complementary
model:
dS = [µK − cβ(I + bJ)S − µS] dt− σg(S, I, J)dB(t),
dI = [cβ(I + bJ)S − (µ+ k1)I + αJ ] dt+ σg(S, I, J)dB(t),
dJ = [k1I − (µ+ k2 + α)J ] dt,
dA = [k2J − (µ+ δ)A] dt. (7.1)
We describe the parameters. The term µK is the recruitment rate of the population and
µ is the average death rate by natural causes, c is the average number of contacts of an
individual per unit time, see Cai [12]. The term β is the probability of disease trans-
mission per contact by an infective in the first stage. The term bβ is the probability of
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disease transmission per contact by an infective in the second stage. By k1 and k2 we
denote the transfer rates from the asymptomatic phase I to the symptomatic phase J
and from the symptomatic phase to the AIDS cases, respectively. α is regarded as the
treatment rate from symptomatic phase J to the asymptomatic phase I. The constant δ
is the disease-related death rate of the AIDS cases. The parameter σ is referred to as the
perturbation parameter.
The basic reproduction number for the deterministic model (σ = 0) has already been
computed in the paper of Cai et. al [12], thus we have
R0 =
cβK(µ+ k2 + α + bk1)
(µ+ k1)(µ+ k2) + µα
. (7.2)
7.3 Stability of Solutions
Like with any ordinary and partial differential equations in a deterministic setting (ODE’s
and PDE’s), the two most basic questions on an SDE system are those of existence and
uniqueness of solutions. To obtain existence and uniqueness results, one has to impose
reasonable regularity conditions on the coefficients occurring in the differential equation.
Naturally stochastic differential equations (SDE’s) contain all the complications of their
non-stochastic counterparts and more.
Existence and positivity of global solutions are sometimes hard to prove. In special cases,
those with independent perturbation, there is a method that works well. In other cases,
mostly where the interest is in endemic equilibria, it is difficult to prove the positivity by
similar methods. We shall avoid it here. Our aim is to study stability, assuming that we
have positive global solutions.
The following lemma is useful in studying exponential stability. We quote it from [50].
Lemma 7.1. For k ∈ N , let X(t) = (X1(t), X2(t), ..., Xk(t)) be a bounded Rk-valued
function and let (t0,n) be any increasing unbounded sequence of positive real numbers.
Then there is a family of sequences (tl,n) such that for each l ∈ {1, 2, ..., k}, (tl,n) is a
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subsequence of (tl−1,n) and the sequence Xl(tl,n) converges to the largest limit point of
the sequence Xl(tl−1,n).
The following numbers will play a key role in the main theorem. Let ξ0, ξ1, ξ2, ξ3 and ξ4
be positive numbers, chosen as follows:
ξ1 = µ+ k2 + α + bk1,
ξ2 = α + bµ+ bk1,
ξ4 = (µ+ k1)(µ+ k2) + µα.
The numbers ξ0 and ξ3 will be chosen later. For now we just bear in mind that they are
both positive. Let m = ξ2ξ
−1
1 . In the sequel we shall consider only the case
g(S, I, J) =
√
2(I +mJ) (7.3)
of the model above. Now for any y ≥ 0, we define the number:
P (y) = cβK(1− yσ2)ξ1
ξ4
.
The following number, which we shall denote by Rσ, will describe the almost sure expo-
nential stability of model (7.1):
Rσ = max {P (1), P (m)} .
We further expand Rσ to be:
Rσ = R0(1− σ2min(1, ξ2ξ−11 )).
We continue by preparing notation and concepts for our main theorem, which is the the-
orem on almost sure exponential stability.
Suppose we have a positive solution (S(t), I(t), J(t), A(t)).
Let
Z(t) = ξ0(K − S(t)) + ξ1I(t) + ξ2J(t) + ξ3A(t)
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and let
V (t) = lnZ(t),
Thus we have the following
V (t) = ln
(
ξ0(K − S(t)) + ξ1I(t) + ξ2J(t) + ξ3A(t)
)
.
We now calculate LV , given by the formula.
LV =
∂V
∂t
+ f trp
∂V
∂x
+
1
2
Trc
[
gtrp
∂2V
∂x2
g
]
,
where Trc means trace and trp denotes the transpose of a matrix.
LV = − 1
Z
ξ0 [µq − cβ(I + bJ)S − µS]− 1
2
[
ξ20σ
2g2
Z2
]
+
ξ1
Z
[cβ(I + bJ)S − (µ+ k1)I + αJ ]− 1
2
[
ξ21σ
2g2
Z2
]
+
ξ0
Z
[k1I − (µ+ k2 + α)J ] + ξ3
Z
[k2J − (µ+ δ)A]
−
[
ξ0ξ1σ
2g2
Z2
]
Now we define the following limits:
s = lim
n→∞
S(tn), i = lim
n→∞
I(tn)
Z(tn)
, j = lim
n→∞
J(tn)
Z(tn)
, a = lim
n→∞
A(tn)
Z(tn)
,
and
q = lim
n→∞
K − S(tn)
Z(tn)
.
These limits exist due to Theorem 7.1.
In particular we note that ξ0q + ξ1i+ ξ2j + ξ3a = 1 and ξ0q, ξ1i, ξ2j, ξ3a ∈ [0,1].
Then we define F (ξ) as:
F (ξ0, ξ1, ξ2, ξ3) = lim sup
t→∞
LV (t).
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Therefore F (ξ) takes the form:
F (ξ) = ξ0 [−µq + cβ(i+ bj)s] + ξ1 [cβ(i+ bj)s− (µ+ k1)i+ αj]
+ ξ2 [k1i− (µ+ k2 + α)j] + ξ3 [k2j − (µ+ d)a]
− 1
2
[
(ξ0 + ξ1)
√
2σ(i+mj)
]2
.
7.4 The main theorem
Theorem 7.2. The disease free equilibrium of the system (7.1) is almost surely expo-
nentially stable if
lim sup
t→∞
LV (X(t)) < 0 (a.s.).
Proof. We start off by noting that
V (X(t)) = V (X(0)) +
∫ t
0
LV (X(u))du+ (ξ1 − ξ0)σ
∫ t
0
g(S(u), I(u), J(u))
Z(X(u))
dW (u).
Note that the quadratic variation of the stochastic integral
∫ t
0
g(S(u), I(u), J(u))
Z(u)
dW (u)
is
∫ t
0
(g(S(u), I(u), J(u))
z(X(u))
)2
du
In view of the condition on g in (7.3), it follows that
|g|
z
≤
3∑
i=0
|gi+1|
ξi
≤
3∑
i=0
Ci+1
ξ
= C,
and C is a uniform (finite) upper bound.
Consequently
∫ t
0
( g
z(X(u))
)2
du ≤ Ct.
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The strong law of large numbers for local martingales, see [33] for instance, implies that
lim
t→∞
1
t
∫ t
0
g(S(u), I(u), J(u))
z(X(u))
dW (u) = 0 (a.s.)
Also, we observe that
lim
t→∞
1
t
V (X(0)) = 0.
Therefore
lim sup
t→∞
1
t
V (X(t)) = lim sup
t→∞
1
t
∫ t
0
LV (X(u))du (a.s.)
This completes the proof. 
Theorem 7.3 If Rσ < 1, then restricted to the subset Ω1, the infection-free equilibrium
E0 is almost surely exponentially stable, where
Ω1 = {w ∈ Ω | (S(t, w(t))), I(t, w(t)), J(t, (w(t))), A(t, w(t)) ∈ ∆ for t ≥ 0}
.
Proof. Let us assume that Rσ < 1. It suffices to prove that Z(t) a.s. converges expo-
nentially to 0 since all the numbers ξi are positive. By definition (7.1) it suffices to prove
that F (ξ) <. The idea is now to find values of ξ0 and ξ3, if possible, such that
F (ξ) < 0.
The number ξ0 is chosen sufficiently small such that the following two inequalities hold:
ξ0(cβK + σ
2) + [(µ+ k1)(µ+ k2) + µα] (P (1)− 1) < 0.
ξ0(bcβK +mσ
2) + b [(µ+ k1)(µ+ k2) + µα] [P (m)− 1] < 0.
Having chosen ξ0, the number ξ3 is chosen sufficiently small such that the following in-
equality holds:
ξ0(bcβK +mσ
2) + b [(µ+ k1)(µ+ k2) + µα] [P (m)− 1] + k2ξ3 < 0.
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Noting that s < K, and rearranging the terms, we obtain the following inequality:
F (ξ) ≤ q(−µξ0) + i [cβK(ξ0 + ξ1)− (µ+ k1)ξ1 + k1ξ2]
+ j [cβK(ξ0 + ξ1)b+ αξ1 − (µ+ k2 + α)ξ2 + k2ξ3]
+ a(−(µ+ α)ξ3)− [(ξ0 + ξ1)σ(i+mj)]2 .
Now we simplify the term in the F -inequality that comes from the diffusion part. We
denote it by D.
D = −σ2(ξ0 + ξ1)2(i+mj)2
≤ −σ2ξ21 [i+mj]2
= −σ2(ξ1i+ ξ2j)2.
Since ξ1i+ ξ2j = 1− ξ0q − ξ3a we get:
D ≤ −σ2(ξ1i+ ξ2j)(1− ξ0q − ξ3a)
= −σ2(ξ1i+ ξ2j) + σ2(ξ1i+ ξ2j)(ξ0q − ξ3a)
≤ −σ2(ξ1i+ ξ2j) + σ2(ξ0q − ξ3a),
The latter inequality follows because ξ1i+ ξ2j ≤ 1. Therefore we can express F (ξ) in an
inequality as follows:
F (ξ) = C0q + C1i+ C2j + C3a,
where
C0 = ξ0(−µ+ σ2),
C3 = ξ3(−µ+ α + σ2),
C1 = ξ0(cβK + σ
2) + cβKξ1 − (µ+ k1)ξ1 + k1ξ2 − ξ1σ2,
C2 = ξ0(cβKb+mσ
2) + cβKbξ1 + αξ1 − (µ+ k2 + α)ξ2 + ξ3k2 − ξ2σ2 .
By the assumptions we have C0 < 0 and C3 < 0. Regarding C1, we note that
−(µ+ k1)ξ1 + k1ξ2 = −(µ+ k1)(µ+ k2)− µα = −ξ4,
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and therefore
C1 = ξ0(cβK + σ
2) + [(µ+ k1)(µ+ k2) + µα]
(
P (1)− 1
)
< 0.
Also note that
αξ1 − (µ+ k2 + α)ξ2 = −b [(µ+ k1)(µ+ k2) + µα] ,
and thus
C2 = ξ0(bcβK +mσ
2) + bcβKξ1 − b [(µ+ k1)(µ+ k2) + µα] + ξ3k2 − ξ2σ2
= ξ0(bcβK +mσ
2) + b [(µ+ k1)(µ+ k2) + µα] [P (m)− 1] + k2ξ3 < 0.
This implies that also C2 < 0. Note that the limits q, i, j, a cannot all be zero. So F < 0
and this completes the proof. 
7.5 Numerical Simulation
In this section we simulate the model (7.1) at different set of parameters. The fig.(7.1)
and (7.2) show the variation of S(t), I(t), J(t), A(t) within time that is the disease free
equilibrium and the endemic equilibrium. In the figures in (7.2)-(7.5), we use them to
verify the greatness of a noise in cases where R0 < 1 and R0 > 1. The figures (7.4) and
(7.5) shows that whenever R0 < 1, then (S(t), I(t), J(t), A(t)) converge almost surely to
E0. In fig.(7.3) the endemic equilibrium becomes more unstable due to the noise and the
solution of the model system (7.1) converges to almost surely to E0 when R0 > 1.
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Figure 7.1: Stochastic trajectories epidemic model (7.1) for the parameters values: K =
120, δ = 0.2, α = 0.2, β = 0.0099, b = 0.07, µ = 0.098, c = 0.059, k1 = 0.05, k2 = 0.04,
σ = 0.
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Figure 7.2: Stochastic trajectories of epidemic model (7.1) for the parameters values:
K = 120, δ = 0.2, α = 0.2, β = 0.02, b = 0.07, µ = 0.098, c = 0.059, k1 = 0.05, k2 = 0.04,
σ = 0.
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Figure 7.3: Stochastic trajectories of epidemic model (7.1) for the parameters values:
K = 120, δ = 0.2, α = 0.2, β = 0.02, b = 0.07, µ = 0.099, c = 0.059, k1 = 0.05, k2 = 0.04,
σ = 0.079.
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Figure 7.4: Stochastic trajectories of epidemic model (7.1) for the parameters values:
K = 120, δ = 0.2, α = 0.2, β = 0.01013, b = 0.85, µ = 0.02, c = 0.03, k1 = 0.08,
k2 = 0.09, σ = 0.060.
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Figure 7.5: Stochastic trajectories of epidemic model (7.1) for the parameters values:
K = 120, δ = 0.2, α = 0.2, β = 0.01013, b = 0.85, µ = 0.02, c = 0.03, k1 = 0.08,
k2 = 0.09, σ = 0.080.
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Chapter 8
Conclusion
In this dissertation we have been dealing with HIV/AIDS treatment model with pub-
lic health education. How can we find ways to stabilize the HIV/AIDS? We have seen
throughout the paper that we were using R0 as a threshold quantity that determines
whether a disease can invade a population. In Chapter 3 we specifically considered global
stability of the disease free equilibrium and simulations. By using all treatment methods,
individuals with the symptomatic phases can be recovered back into the asymptomatic
class. The dynamics behavior of the ordinary differential equation treatment model (5.2)
can be determined by its basic reproduction number R0, for example if R0 ≤ 1, the
disease-free equilibrium is globally stable. If R0 > 1, the disease persists and the unique
endemic equilibrium is globally asymptotically stable. We use the optimal control theory
to identify optimal roll-out of strategies to control the HIV/AIDS.
We looked also on the stochastic model describing the population dynamics of an HIV/AIDS
epidemic. We proved the almost sure exponential stability of the system (7.1) under suit-
able conditions. We have proved in particular that the stochastic perturbation does not
destabilize the disease free equilibrium, i.e., whenever R0 < 1, then the disease free equi-
librium is almost surely exponentially stable.
Instead of waiting for disease-related symptoms, creating awareness in the population
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through campaigns about the disease is necessary for individuals to get tested early and
know their HIV status. Depending on how much effort is invested and how the popula-
tion responds to the information, campaigns help early testing. Once knowing their HIV
status, the starting time of the treatment is decided by the countries policy on treatment.
In our theoretical strategy, every HIV positive individual is eligible for treatment irrespec-
tive of the age of infection, in other words irrespective of the CD4+ count. Introducing
treatment at different ages of infection before developing AIDS-related diseases affects the
dynamics to reduce the effective reproduction number even though it is greater than one
and the disease remains endemic in the population.
In all the Models above public health Campaign plays a very important role in decreasing
the spread of HIV/AIDS. In all the three model we have seen that total withdrawal
from sexual activities of some HIV positive individuals has a great potential to tame the
HIV/AIDS epidemic. Educating those infected with HIV/AIDS and those around them
on the effects of the disease, how it is transmitted, safe sex practices may cause behavioral
changes that can reduce HIV/AIDS infections. We have also noted that by giving free
antiretroviral drug to HIV positive individuals in countries where the resources are limited
can reduce HIV/AIDS. In Bhunu et al. [7], individual who are getting tested and changing
the sexual behavior would mean being put to antiretroviral drug and having one’s health
improved. In all the three model education is the key to reduce the effect of HIV/AIDS,
as individual turn to withdraw or decrease in sexual behavior.
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